Sant Pau - Institut de Recerca

El Grupo de Investigación en Salud Mental Sant Pau desarrolla líneas de investigación eminentemente clínicas que buscan dar respuesta a las necesidades de las personas atendidas en el Servicio de Psiquiatría del Hospital de la Santa Creu i Sant Pau, abarcando así un amplio espectro de los trastornos psiquiátricos y la salud mental.

Principales líneas de investigación

Trastornos Afectivos y Suicidio: esta línea de investigación estudia el trastorno depresivo mayor y el suicidio, en estrecha colaboración con otras líneas de investigación dentro del grupo.
Jefes de línea: Narcís Cardoner y Javier de Diego.
Trastornos Psicóticos: estudios relacionados con la esquizofrenia resistente y el tratamiento metacognitivo para pacientes con esquizofrenia.
Jefes de línea: Eva Grasa y Alexandra Roldán.
Trastorno Límite de la Personalidad: investigación en nuevos enfoques psicoterapéuticos de tercera generación como Mindfulness, Terapia Dialéctica Conductual, Terapia de Aceptación y Compromiso y psicología positiva.
Jefe de línea: Joaquim Soler.
Trastornos de la Conducta Alimentaria: investigación orientada a estrategias de tratamiento basadas en la evidencia, principalmente intervenciones conductuales, con proyectos en marcha.
Jefes de línea: Mar Carceller Sindreu y Cristina Carmona.
Hospitalización Parcial en Domicilio (UPHAD) e Intervención Comunitaria: esta línea está centrada en estudios que evalúan las experiencias de atención de pacientes y cuidadores, así como la mejora de los tratamientos domiciliarios, con el objetivo de mejorar la calidad de vida de las personas.
Jefe de línea: Ana Martín Blanco.
Conductas Adictivas: estudios enfocados en el ámbito de los trastornos adictivos, incluyendo la perspectiva del usuario. Desarrollo y validación de escalas de satisfacción.
Jefe de línea: Joan Trujols.

Retos

Fomentar la investigación para reducir los costes sanitarios, sociales y personales de la enfermedad mental mediante la exploración de varias áreas como la epidemiología, etiopatogénesis, fisiopatología, prevención y tratamiento.
Fomentar la investigación en terapias de salud mental.
Fomentar la investigación para mejorar la calidad de vida de pacientes con trastornos mentales.

Coordinación del grupo

PORTELLA MOLL, MARIA JESUS IR
mportella@santpau.cat

Miembros

Alemany Santamaria, Carlo FGS

Almenta Gallego, David FGS

Avila Parcet, Aina FGS

Borrell Pozo, Julia IR

Cano Catala, Marta IR

Carceller Sindreu, Maria del Mar FGS

Cardoner Alvarez, Narcis FGS

Carmona Farres, Cristina FGS

Carrasco Hernandez, Julia IR

Casellas Pujol, Elisabet FGS

Corripio Collado, Iluminada IR

De Diego Adeliño, Francisco Javier FGS

De la Peña Arteaga, Victor IR

Diaz Perez, Anna M. FGS

Farre Martinez, Adriana FGS

Faustino Bosch, Gloria IR

Gawron, Leonor Patricia FGS

Grasa Bello, Eva Maria CIBERSAM

Jaramillo Muñumer, Maria CIBERSAM

Jubero Urgell, Miriam IR

Madre Rull, Merce FGS

Martin Blanco, Ana FGS

Otero Castellanos, Daniela IR

Pascual Mateos, Juan Carlos FGS

Perez Blanco, Josefina FGS

Pousa Tomas, Esther FGS

Puigdemont Campos, Maria Dolors FGS

Roldan Bejarano, Alejandra FGS

Serrano Gimeno, Victor FGS

Soler Ribaudi, Joaquin FGS

Tiana Sastre, Thais FGS

Trujols Albet, Joan FGS

Vicent Gil, Muriel FGS

Publicaciones 2023

(JIF 2023)

-Aibar JA, Collado IC, Bejarano AR, Nevado RS, Bolanos IA, Garcia J, Alonso A, Bello E, Schmidt CD, Hernandez FM, Teixido JM, Rodriguez RR. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets. JOURNAL OF PSYCHIATRIC RESEARCH. 2023; 163. DOI:10.1016/j.jpsychires.2023.05.056. PMID:37245316. IF:3,700 (Q1/3D). Document type: Article.

-Alcantarilla L, López M, Betriu M, Torres A, Garcia C, Solé E, Gelabert E, Roca A. Risk factors for relapse or recurrence in women with bipolar disorder and recurrent major depressive disorder in the perinatal period: a systematic review. Archives of Womens Mental Health. 2023; 26(6). DOI:10.1007/s00737-023-01370-9. PMID:37718376. IF:3,200 (Q2/4D). Document type: Review.

-Alemany C, Puigdemont D, Martín A, Rodríguez R, Aibar JA, Vicent M, Álvarez E, Pérez V, Portella MJ, de Diego J. Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study. JOURNAL OF CLINICAL PSYCHIATRY. 2023; 84(4):22m14622. DOI:10.4088/JCP.22M14622. PMID:37378475. IF:4,500 (Q1/1D). Document type: Article.

-Arca G, Nunez C, Stephan C, Arnaez J, Agut T, Cordeiro M, Boronat N, Lubian S, Benavente I, Valverde E, Garcia A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144. DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3,200 (Q1/2D). Document type: Article.

-Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van JA, Tendolkar I, van P, van GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano C, Cardoner N, Cano M, van L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PCR, Redlich R, Dannlowski U, Erhan K, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. MOLECULAR PSYCHIATRY. 2023; DOI:10.1038/s41380-023-02318-2. PMID:37985787. IF:9,600 (Q1/1D). Document type: Article.

-Baeza I, de la Serna E, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Diaz CM, Corripio I, Valli I, Puig O, Mane A, Bioque M, Ayora M, Bernardo M, Castro J, PEPs GRP. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; DOI:10.1007/s00787-023-02196-7. PMID:37027026. IF:6,000 (Q1/1D). Document type: Article.

-Blanken MAJT, Oudega ML, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, Van L, Birkenhager T, Schrijvers D, Redlich R, Dannlowski U, Heindel W, Coenjaerts M, Nordanskog P, Oltedal L, Kessler U, Frid LM, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Bolwig T, Emsell L, Sienaert P, Bouckaert F, Abbott CC, Péran P, Arbus C, Yrondi A, Kiebs M, Philipsen A, van JA, Prinsen E, van M, Van G, ten F, Camprodon JA, Kritzer M, Barbour T, Argyelan M, Cardoner N, Urretavizcaya M, Soriano C, Narr KL, Espinoza RT, Prudic J, Rowny S, van P, Tendolkar I, Dols A. Sex-specifics of ECT outcome. JOURNAL OF AFFECTIVE DISORDERS. 2023; 326. DOI:10.1016/j.jad.2022.12.144. PMID:36632848. IF:4,900 (Q1/2D). Document type: Article.

-Butjosa A, Usall J, Vila R, Mezquida G, Cuesta MJ, Rodriguez E, Amoretti S, Lobo A, Gonzalez A, Espliego A, Corripio I, Vieta E, Baeza I, Berge D, Bernardo M. Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. 2023; 69(1):00207640211070398. DOI:10.1177/00207640211070398. PMID:35068217. IF:2,500 (Q2/5D). Document type: Article.

-Cano M, Camprodon JA. Understanding the Mechanisms of Action of Electroconvulsive Therapy Revisiting Neuroinflammatory and Neuroplasticity Hypotheses. JAMA Psychiatry. 2023; 80(6). DOI:10.1001/jamapsychiatry.2023.0728. PMID:37074712. IF:22,500 (Q1/1D). Document type: Editorial Material.

-Cano M, Lee E, Polanco C, Barbour T, Ellard KK, Andreou B, Uribe S, Henry ME, Seiner S, Cardoner N, Soriano C, Camprodon JA. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression. JOURNAL OF AFFECTIVE DISORDERS. 2023; 333. DOI:10.1016/j.jad.2023.03.093. PMID:37024015. IF:4,900 (Q1/2D). Document type: Article.

-Contreras O, Reales M, Fernandez S, Cimpean A, Arnoriaga M, Puig J, Biarnes C, Motger A, Cano M, Fernandez JM. Consumption of ultra-processed foods is associated with depression, mesocorticolimbic volume, and inflammation. JOURNAL OF AFFECTIVE DISORDERS. 2023; 335. DOI:10.1016/j.jad.2023.05.009. PMID:37207947. IF:4,900 (Q1/2D). Document type: Article.

-Costas A, Verdolini N, Garcia C, Mezquida G, Janssen J, Valli I, Corripio I, Sanchez AM, Bioque M, Lobo A, Gonzalez A, Rapado M, Vieta E, de la Serna H, Mane A, Roldan A, Crossley N, Penades R, Cuesta MJ, Parellada M, Bernardo M, PEPs GRP. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis. PSYCHOLOGICAL MEDICINE. 2023; DOI:10.1017/S0033291723003185. PMID:38014924. IF:5,900 (Q1/1D). Document type: Article.

-de la Serna E, Montejo L, Solé B, Castro-Fornieles J, Camprodon-Boadas P, Sugranyes G, Rosa-Justicia M, Martinez-Aran A, Vieta E, Vicent-Gil M, Serra-Blasco M, Cardoner N, Torrent C. Effectiveness of enhancing cognitive reserve in children, adolescents and young adults at genetic risk for psychosis: Study protocol for a randomized controlled trial. Span J Psychiatry Ment Health. 2023;16(3):184-191. DOI: 10.1016/j.rpsm.2021.02.003. PMID: 33631372. Document type: Article.

-De la Serna E, Puig O, Mezquida G, Moreno L, Merchan J, Amoretti S, Ruiz P, Gonzalez A, Molina M, Corripio I, Vieta E, Baeza I, Berge D, Penades R, Sanchez A, Cuesta MJ, Bernardo M, Castro J. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; 32(4). DOI:10.1007/s00787-021-01901-8. PMID:34714406. IF:6,000 (Q1/1D). Document type: Article.

-Fagiolini A, Cardoner N, Pirildar S, Ittsakul P, Ng B, Duailibi K, El Hindy N. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. EXPERT OPINION ON PHARMACOTHERAPY. 2023; 24(15). DOI:10.1080/14656566.2023.2242264. PMID:37501324. IF:2,500 (Q3/6D). Document type: Review.

-Florido A, Velasco ER, Monari S, Cano M, Cardoner N, Sandi C, Andero R, Perez L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224:109344. DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4,600 (Q1/2D). Document type: Article.

-Fortea L, Tortella-Feliu M, Juaneda-Seguí A, De la Peña-Arteaga V, Chavarría-Elizondo P, Prat-Torres L, Soriano-Mas C, Lane SP, Radua J, Fullana MA. Development and Validation of a Smartphone-Based App for the Longitudinal Assessment of Anxiety in Daily Life. Assessment. 2023 Jun;30(4):959-968. DOI: 10.1177/10731911211065166. Epub 2021 Dec 30. PMID: 34969314; PMCID: PMC9301625. IF:3,500 (Q1/2D). Document type: Article.

-Fraguas D, Almenta D, Arques S, Gómez M, Sánchez CG, Hernández D, Núñez D, Oda Plasencia B, Parro C, Romero SL, Ros E, Alamo C. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1). DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:2,900 (Q2/4D). Document type: Review.

-García J, Hijar R, López Y, Magallón R, Fernández S, Barceló A, Soler J, Montero J. Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial. Trials. 2023; 24(1):125. DOI:10.1186/s13063-023-07151-0. PMID:36805694. IF:2,000 (Q3/7D). Document type: Article.

-Goodman JM, Cuesta D, Alupoaei C, Bello E, Herrera J, Mayoral F, Guzman J. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14:1178341. DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2,600 (Q2/3D). Document type: Article.

-Gracia R, Portella MJ, Puntí J, Pujals E, Torralbas J, Llorens M, Pamias M, Fradera M, Montalvo I, Palao DJ. COVID-19 Pandemic Has Changed the Psychiatric Profile of Adolescents Attempting Suicide: A Cross-Sectional Comparison. International Journal of Environmental Research and Public Health. 2023; 20(4):2952. DOI:10.3390/ijerph20042952. PMID:36833651. Document type: Article.

-Grasa E, Corripio I, Peris O, Roldán A, Selma J, Osma J. Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain. Clinical Case Studies. 2023; DOI:10.1177/15346501231190912. IF:0,800 (Q4/9D). Document type: Article.

-Grasa E, Seppala J, Alonso A, Haapea M, Isohanni M, Miettunen J, Mendivelso JC, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J, RESIST MGRP, Corripio I. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. Jmir Formative Research. 2023; 7:e46179. DOI:10.2196/46179. PMID:37389933. IF:2,000 (Q3/6D). Document type: Article.

-Groenewold NA, Bas-Hoogendam JM, Amod AR, Laansma MA, Van Velzen LS, Aghajani M, Hilbert K, Oh H, Salas R, Jackowski AP, Pan PM, Salum GA, Blair JR, Blair KS, Hirsch J, Pantazatos SP, Schneier FR, Talati A, Roelofs K, Volman I, Blanco-Hinojo L, Cardoner N, Pujol J, Beesdo-Baum K, Ching CRK, Thomopoulos SI, Jansen A, Kircher T, Krug A, Nenadić I, Stein F, Dannlowski U, Grotegerd D, Lemke H, Meinert S, Winter A, Erb M, Kreifelts B, Gong Q, Lui S, Zhu F, Mwangi B, Soares JC, Wu MJ, Bayram A, Canli M, Tükel R, Westenberg PM, Heeren A, Cremers HR, Hofmann D, Straube T, Doruyter AGG, Lochner C, Peterburs J, Van Tol MJ, Gur RE, Kaczkurkin AN, Larsen B, Satterthwaite TD, Filippi CA, Gold AL, Harrewijn A, Zugman A, Bülow R, Grabe HJ, Völzke H, Wittfeld K, Böhnlein J, Dohm K, Kugel H, Schrammen E, Zwanzger P, Leehr EJ, Sindermann L, Ball TM, Fonzo GA, Paulus MP, Simmons A, Stein MB, Klumpp H, Phan KL, Furmark T, Månsson KNT, Manzouri A, Avery SN, Blackford JU, Clauss JA, Feola B, Harper JC, Sylvester CM, Lueken U, Veltman DJ, Winkler AM, Jahanshad N, Pine DS, Thompson PM, Stein DJ, Van der Wee NJA. Volume of subcortical brain regions in social anxiety disorder: mega-analytic results from 37 samples in the ENIGMA-Anxiety Working Group. Mol Psychiatry. 2023;28(3):1079-1089. DOI: 10.1038/s41380-022-01933-9. PMID: 36653677. IF:9,600 (Q1/1D). Document type: Article.

-Gutiérrez F, Aluja A, Rodríguez C, Gárriz M, Peri JM, Gallart S, Calvo N, Ferrer M, Gutiérrez A, Soler J, Pascual JC. Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample. Frontiers in Psychiatry. 2023; 13:1015489. DOI:10.3389/fpsyt.2022.1015489. PMID:36699492. IF:3,200 (Q2/4D). Document type: Article.

-Joseph Fortuny J, Navarra-Ventura G, Fernández-Gonzalo S, Pousa Tomàs E, Crosas Armengol JM, Palao Vidal D, Jodar Vicente M. Social cognition in first-episode schizophrenia/schizoaffective disorder patients. Span J Psychiatry Ment Health. 2023;16(3):169-174. DOI: 10.1016/j.rpsm.2020.04.006. PMID: 32499122. Document type: Article.

-Lin BD, Pinzon J, Blouzard E, van der Horst MZ, Okhuijsen C, van KR, Guloksuz S, Peyrot WJ, Luykx JJ, Genetic Risk Outcome Psychosis GRP, Clozapine Int Consortium CLOZIN IN. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA Psychiatry. 2023; 80(2). DOI:10.1001/jamapsychiatry.2022.4234. PMID:36542388. IF:22,500 (Q1/1D). Document type: Article.

-Mateo C, Sanabria JP, Comendador L, Rojas JS, Carmona M, Crespo N, Anyosa F, Selva C, Feliu A, Cardoner N, Deus J, Luciano JV, Mendez JL, Sanz A. Predictive factors of hesitancy to vaccination against SARS-CoV-2 virus in young adults in Spain: Results from the PSY-COVID study. Vaccine: X. 2023; 14:100301. DOI:10.1016/j.jvacx.2023.100301. PMID:37091731. IF:2,700 (Q3/6D). Document type: Article.

-Mezquida G, Amoretti S, Bioque M, García C, Sánchez AM, Pina L, Lopez P, Mané A, Rodriguez R, Corripio I, Sarró S, Ibañez A, Usall J, García MP, Vieta E, Mas S, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, 2EPs G. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2023; 16(3). DOI:10.1016/j.rpsm.2023.01.004. PMID:37716849. Document type: Article.

-Navarrete J, Colomer A, Sanabria JP, Luciano JV, Soler J, Garcia J, Demarzo M, Montero J, Bohlmeijer ET, Campos D, Cebolla A, Feliu A. Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims. Journal of Contextual Behavioral Science. 2023; 28. DOI:10.1016/j.jcbs.2023.05.001. IF:3,400 (Q1/2D). Document type: Article.

-Navarrete J, Fontana M, Colomer A, Sanabria JP, Pinazo D, Silvestre A-J, Lau M, Tanay G, García J, Demarzo M, Soler J, Cebolla A, Feliu A, Luciano JV. The Toronto Mindfulness Scale and the State Mindfulness Scale: psychometric properties of the Spanish versions. Frontiers in Psychology. 2023; 14:1212036. DOI:10.3389/fpsyg.2023.1212036. PMID:37484107IF:2,600 (Q2/3D). Document type: Article.

-Nunez C, Garcia A, Arca G, Agut T, Carreras N, Portella MJ, Stephan C. Breastfeeding duration is associated with larger cortical gray matter volumes in children from the ABCD study. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2023; 64(7). DOI:10.1111/jcpp.13790. PMID:36946606. IF:6,500 (Q1/1D). Document type: Article.

-Oteo Á, García CG, Sánchez AI, Santamaria CA, de Diego J. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10). DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4,200 (Q1/3D). Document type: Review.

-Pascual JC, Arias L, Soler J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6). DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:7,400 (Q1/1D). Document type: Article.

-Porta D, Cano M, Navarra G, Serra M, Vicent M, Solé B, Montejo L, Torrent C, Martinez A, Harrison BJ, Palao D, Vieta E, Cardoner N. Disrupted network switching in euthymic bipolar disorder: Working memory and self-referential paradigms. JOURNAL OF AFFECTIVE DISORDERS. 2023; 320. DOI:10.1016/j.jad.2022.09.152. PMID:36202301. IF:4,900 (Q1/2D). Document type: Article.

-Portella MJ, González I, Jubero M, Trujols J, Pérez V. Depressive-Like Effects of Foreclosing: A Cross-Sectional Study of Hair Cortisol Concentration. PSYCHOPATHOLOGY. 2023; DOI:10.1159/000530706. PMID:37331349. IF:1,900 (Q3/6D). Document type: Article.

-Sanchez AM, Amoretti S, Enguita M, Mezquida G, Moreno L, Panadero R, Rementeria L, Toll A, Rodriguez R, Roldan A, Pomarol E, Ibanez A, Usall J, Contreras F, Vieta E, Lopez JM, Merchan J, Gonzalez A, Berrocoso E, Bernardo M, Cuesta MJ, 2EPs GRP. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 67. DOI:10.1016/j.euroneuro.2022.11.011. PMID:36495858. IF:6,100 (Q1/1D). Document type: Article.

-Sastre A, Caro I, Ochoa S, Lorente E, Barajas A, Gutiérrez A, Sánchez S, López R, Grasa E, Pousa E, Pélaez T, Cid J, González F, Ruiz I, Baca E, Barrigon ML, Spanish Metacognition Study G. Relationship between cognition and suicidal behavior in recent-onset psychosis. SCHIZOPHRENIA RESEARCH. 2023; 252. DOI:10.1016/j.schres.2022.12.042. PMID:36652834. IF:3,600 (Q1/3D). Document type: Article.

-Schmidt C, Briones L, Nicolaou S, Soler J, Pascual JC, Vega D. Non-suicidal self-injury in young adults with and without borderline personality disorder: the role of emotion dysregulation and negative urgency. Anales de Psicologia. 2023; 39(3). DOI:10.6018/analesps.492631. IF:1,400 (Q3/6D). Document type: Article.

-Segal A, Parkes L, Aquino K, Kia SM, Wolfers T, Franke B, Hoogman M, Beckmann CF, Westlye LT, Andreassen OA, Zalesky A, Harrison BJ, Davey CG, Soriano C, Cardoner N, Tiego J, Yücel M, Braganza L, Suo C, Berk M, Cotton S, Bellgrove MA, Marquand AF, Fornito A. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9). DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21,300 (Q1/1D). Document type: Article.

-Segura AG, Mane A, Prohens L, Rodriguez N, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Diaz CM, Bejarano AR, Jimenez E, Baeza I, Legido T, Saiz J, Bernardo M, Mas S, PEPs GRP. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325:115249. DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:4,200 (Q1/2D). Document type: Article.

-Segura AG, Mezquida G, Martinez A, Gasso P, Rodriguez N, Moreno L, Amoretti S, Bioque M, Lobo A, Gonzalez A, Garcia A, Roldan A, Vieta E, de la Serna E, Toll A, Cuesta MJ, Mas S, Bernardo M, PEPs GRP. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10):PII S0033291722001544. DOI:10.1017/S0033291722001544. PMID:35678455. IF:5,900 (Q1/1D). Document type: Article.

-Segura À-G, Prohens L, Gassó P, Rodríguez N, Garcia C, Moreno L, Andreu Á, Zorrilla I, Mane A, Rodriguez R, Roldán A, Sarró S, Ibáñez Á, Usall J, Sáiz PA, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, Mas S, Mezquida G, Arbelo N, De Matteis M, Galvañ J, Duque A, Arias i Queralt L, Perez M, Gonzalez I, Toll A, Casanovas F, Sanchez L, Valtueña M, Pomarol E, García MÁ, Butjosa A, Rubio E, Ribeiro M, López JM, Saiz J, León L, Rivero O, Ruiz P, Echevarría RS, García MP. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75. DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:6,100 (Q1/1D). Document type: Article.

-Trujols J, Vicent M, Duran S, Portella MJ. A truly patient-centred evaluation of opioid agonist treatment. The Lancet Psychiatry. 2023; 10(8). DOI:10.1016/S2215-0366(23)00202-X. PMID:37479338. IF:30,800 (Q1/1D). Document type: Letter.

-Valli I, Segura AG, Verdolini N, Garcia C, Berge D, Baeza I, Cuesta MJ, Gonzalez A, Lobo A, Martinez A, Mezquida G, Pina L, Bejarano AR, Mas S, McGuire P, Bernardo M, Vieta E, PEPs GRP. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1). DOI:10.1111/acps.13546. PMID:36912272. IF:5,300 (Q1/2D). Document type: Article.

-Verdolini N, Mezquida G, Valli I, Garcia C, Cuesta M, Vieta E, Bioque M, Lobo A, Gonzalez A, Pina L, Corripio I, Garriga M, Baeza I, Martinez L, Bitanihirwe B, Cannon M, Bernardo M, PEPs GRP. Obstetric complications and clinical presentation in first episode of psychosis. ACTA NEUROPSYCHIATRICA. 2023; :PII S0924270823000091. DOI:10.1017/neu.2023.9. PMID:36861430. IF:2,600 (Q2/5D). Document type: Article.

-Vicent M, Serra M, Navarra G, Trujols J, Balanza V, Portella MJ, Cardoner N. In pursuit of full recovery in major depressive disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023; 273(5). DOI:10.1007/s00406-022-01487-5. PMID:36085532. IF:3,500 (Q1/3D). Document type: Article.

-Vicent M, Trujols J, Serra M, Navarra G, Puigdemont D, Alemany C, Crivillés S, de Diego J, Cardoner N, Portella MJ. If you feel you can’t, you won’t: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1):e83. DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7,200 (Q1/1D). Document type: Article.

Publicaciones 2022

(JIF 2022)

Aibar JÁ, Rodríguez R, de Diego FJ, Portella MJ, Álvarez MJ, Martín A, Puigdemont D, Molet J. Long-Term Results of Deep Brain Stimulation for Treatment-Resistant Depression: Outcome Analysis and Correlation With Lead Position and Electrical Parameters. Neurosurgery. 2022; 90(1). DOI:10.1227/NEU.0000000000001739. PMID:34982873. IF:4,8 (Q1/1D). Document type: Article.
Alvear D, Soler J, Cebolla A. Meditators’ Non-academic Definition of Mindfulness. Mindfulness. 2022; 13(6). DOI:10.1007/s12671-022-01899-3. PMID:35634214. IF:3,6 (Q2/4D). Document type: Article.
Amoretti S, Rosa AR, Mezquida G, Cabrera B, Ribeiro M, Molina M, Bioque M, Lobo A, Gonzalez A, Fraguas D, Corripio I, Vieta E, de la Serna E, Morro L, Garriga M, Torrent C, Cuesta MJ, Bernardo M, PEPs GRP. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. PSYCHOLOGICAL MEDICINE. 2022; 52(3):PII S0033291720002226. DOI:10.1017/S0033291720002226. PMID:32900395. IF:6,9 (Q1/2D). Document type: Article.
Amoretti S, Verdolini N, Varo C, Mezquida G, Sanchez AM, Vieta E, Garcia C, Lobo A, Gonzalez A, Abregu R, Corripio I, Serra M, de la Serna E, Mane A, Ramos JA, Ribases M, Cuesta MJ, Bernardo M. Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302. DOI:10.1016/j.jad.2022.01.077. PMID:35066012. IF:6,6 (Q1/2D). Document type: Article.
Aragones E, Lopez G, Cardoner N, Tome C, Porta D, Palao D, INDI Res Team I. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses. BMC HEALTH SERVICES RESEARCH. 2022; 22(1):446. DOI:10.1186/s12913-022-07872-z. PMID:35382822. IF:2,8 (Q3/6D). Document type: Article.
Baenas I, Etxandi M, Munguia L, Granero R, Mestre G, Sanchez I, Ortega E, Andreu A, Moize VL, Fernandez JM, Tinahones FJ, Dieguez C, Fruhbeck G, Le D, Tchanturia K, Karwautz A, Zeiler M, Imgart H, Zanko A, Favaro A, Claes L, Shekriladze I, Serrano E, Cecilia R, Rangil T, Loran ME, Soriano J, Carceller M, Navarrete R, Lozano M, Linares R, Gudiol C, Carratala J, et al. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study. 2022; 14(1):100. DOI:10.3390/nu14010100. PMID:35010974. IF:5,9 (Q1/2D). Document type: Article.
Bas JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, Jahanshad N, Thomopoulos SI, Thompson PM, Veltman DJ, Winkler AM, Lueken U, Pine DS, van der Wee NJA, Stein DJ, Agosta F, Åhs F, An I, Alberton BAV, Andreescu C, Asami T, Assaf M, Avery SN, Nicholas L, B, Barber JP, Battaglia M, Bayram A, Beesdo K, Benedetti F, Berta R, Björkstrand J, Blackford JU, et al. [Cardoner N, Porta-Casteràs D]. Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25100. PMID:32618421. IF:4,8 (Q1/2D). Document type: Review.
Bioque M, Matias AC, Llorca V, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Moreno C, Roldan A, Martinez A, Baeza I, Berge D, Garcia C, Herrero SM, Bernardo M, 2EPs GRP. Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study. SCHIZOPHRENIA BULLETIN. 2022; 48(6). DOI:10.1093/schbul/sbac089. PMID:35876785. IF:6,6 (Q1/3D). Document type: Article.
Bioque M, Mezquida G, Amoretti S, Garcia C, Lopez JM, Diaz CM, Zorrilla I, Mane A, Rodriguez R, Corripio I, Pomarol E, Ibanez A, Usall J, Contreras F, Mas S, Vazquez J, Cuesta MJ, Parellada M, Gonzalez A, Hidalgo M, Bernardo M, 2EPs GRP. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2022; 243. DOI:10.1016/j.schres.2022.02.026. PMID:35231832. IF:4,5 (Q2/4D). Document type: Article.
Cano M, Lee E, Worthley A, Ellard K, Barbour T, Soriano C, Camprodon JA. Electroconvulsive therapy effects on anhedonia and reward circuitry anatomy: A dimensional structural neuroimaging approach. JOURNAL OF AFFECTIVE DISORDERS. 2022; 313. DOI:10.1016/j.jad.2022.06.062. PMID:35764228. IF:6,6 (Q1/2D). Document type: Article.
Cobo J, Coronas R, Pousa E, Oliva J-C, Giménez O, Caixàs A. An adapted scale to evaluate insight in Prader-Willi Syndrome. MEDICINA CLINICA. 2022; 159(3). DOI:10.1016/j.medcli.2021.07.015. PMID:34696903. IF:3,9 (Q2/4D). Document type: Article.
Corripio I, Roldan A, McKenna P, Sarro S, Alonso A, Salgado L, Alvarez E, Molet J, Pomarol E, Portella M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112:110436. DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5,6 (Q1/2D). Document type: Article.
Cuesta MJ, Ballesteros A, Sanchez AM, Amoretti S, Lopez JM, Merchan J, Gonzalez I, Salgado P, Rodriguez R, Roldan A, Sarro S, Ibanez A, Usall J, Escarti MJ, Moreno L, Mezquida G, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, 2Eps GRP. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden. SCHIZOPHRENIA RESEARCH. 2022; 248. DOI:10.1016/j.schres.2022.09.014. PMID:36155307. IF:4,5 (Q2/4D). Document type: Article.
De Diego J, Crespo JM, Mora F, Neyra A, Iborra P, Gutierrez L, Salonia SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opinion On Drug Safety. 2022; 21(5). DOI:10.1080/14740338.2022.2019705. PMID:34964415. IF:3,1 (Q3/6D). Document type: Review.
Diaz L, Lopez R, Garcia H, Ferrer M, Verdaguer M, Barajas A, Grasa E, Pousa E, Lorente E, Barrigon ML, Ruiz I, Gonzalez F, Cid J, Mas L, Corripio I, Birules I, Pelaez T, Luengo A, Beltran M, Torres P, Palma C, Moritz S, Garety P, Ochoa S, Spanish GRP. The relationship between jumping to conclusions and social cognition in first-episode psychosis. SCHIZOPHRENIA. 2022; 8(1):39. DOI:10.1038/s41537-022-00221-3. PMID:35853903. Document type: Article.
Dima D, Modabbernia A, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, et al. [Portella MJ]. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25320. PMID:33570244. IF:4,8 (Q1/2D). Document type: Article.
Dominguez E, Soler J, Elices M, Franquesa A, Alvarez E, Pascual JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2022; 37(1):e2807. DOI:10.1002/hup.2807. PMID:34411343. IF:1,7 (Q3/8D). Document type: Article.
Erausquin JT, Sánchez J, Yu A, Jhangimal M, Millender E, Peña Y, Ng W, Reina A, Nakad C, Quintana J, Herrera R, Vistica G, Pinzón J, Cabezas G, Katz J, Pascale JM, Rodríguez F, Gabster A. Sexual and reproductive health and access: Results of a rapid epidemiological assessment among migrant peoples in transit through Darién, Panamá. Frontiers In Reproductive Health. 2022; 4:953979. DOI:10.3389/frph.2022.953979. Document type: Article.
Ferrer M, Fernandez D, Lopez R, Birules I, Barajas A, Lorente E, Luengo A, Diaz L, Verdaguer M, Garcia H, Gutierrez A, Grasa E, Pousa E, Huerta E, Pelaez T, Barrigon ML, Gomez J, Gonzalez F, Ruiz I, Cid J, Moritz S, Sevilla J, Ochoa S, Spanish GRP. Males and females with first episode psychosis present distinct profiles of social cognition and metacognition. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022; 272(7). DOI:10.1007/s00406-022-01438-0. PMID:35802165. IF:4,7 (Q1/3D). Document type: Article.
Ferrer M, Fernandez D, Lopez R, Diaz L, Verdaguer M, Garcia H, Huerta E, Gomez J, Pelaez T, Birules I, Barajas A, Pousa E, Barrigon M, Gutierrez A, Grasa E, Ruiz I, Lorente E, Cid J, Ochoa S, Spanish Metacognition Study GRP. Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis. 2022; 10(11):2155. DOI:10.3390/healthcare10112155. PMID:36360496. IF:2,8 (Q3/6D). Document type: Article.
Fouche JP, Groenewold NA, Sevenoaks T, Heany S, Lochner C, Alonso P, Batistuzzo MC, Cardoner N, Ching CRK, de Wit SJ, Gutman B, Hoexter MQ, Jahanshad N, Kim M, Kwon JS, Mataix D, Menchon JM, Miguel EC, Nakamae T, Phillips ML, Pujol J, Sakai Y, Yun JY, Soriano C, Thompson PM, Yamada K, Veltman DJ, van den Heuvel OA, Stein DJ. Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium. Brain and Behavior. 2022; 12(10):e2755. DOI:10.1002/brb3.2755. PMID:36106505. IF:3,1 (Q2/3D). Document type: Article.
Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, et al. [Portella MJ]. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25364. PMID:33595143. IF:4,8 (Q1/2D). Document type: Article.
Garcia C, Cabrera B, Bioque M, Mezquida G, Lobo A, Gonzalez A, Diaz CM, Corripio I, Vieta E, Baeza I, Garcia MP, Gutierrez M, Rodriguez R, Garriga M, Fernandez E, Bernardo M, PEPs G. The effect of early life events on glucose levels in first-episode psychosis. Frontiers in Endocrinology. 2022; 13:983792. DOI:10.3389/fendo.2022.983792. PMID:36545332. IF:5,2 (Q1/3D). Document type: Article.
Kong X-Z, Mathias SR, Guadalupe T, Abé C, Akudjedu TN, Aleman A, Alhusaini S, Allen NB, Ames D, Andreassen OA, Vasquez AA, Armstrong NJ, Asherson P, Bergo F, Bastin ME, Batalla A, Bauer J, Baune BT, Baur R, Biederman J, Blaine SK, Boedhoe P, Bøen E, Bose A, Bralten J, Brandeis D, Brem S, Brodaty H, Yüksel D, Brooks SJ, Buitelaar J, Bürger C, Bülow R, Calhoun V, Calvo A, et al. [Portella MJ]. Reproducibility in the absence of selective reporting: An illustration from large-scale brain asymmetry research. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25154. PMID:32841457. IF:4,8 (Q1/2D). Document type: Article.
Lorente E, Grasa E, Ochoa S, Corripio I, Peláez T, López R, Gutiérrez Á, Morano M, Villagrán JM, Bartels AA, Jenner JA, Sanjuán J. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI). Revista de Psiquiatria y Salud Mental. 2022; 15(4). DOI:10.1016/j.rpsm.2020.03.002. PMID:32493672. IF:9,2 (Q1/1D). Document type: Article.
Martín A, Calvo L, Baccarin J, González A, Keymer A, Vieira S, Ribas N, Garcia C. Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice. Revista de Psiquiatria y Salud Mental. 2022; 15(3). DOI:10.1016/j.rpsm.2021.11.001. PMID:36272741. IF:9,2 (Q1/1D). Document type: Letter.
Martínez A, Mezquida G, Bioque M, López JM, Andreu Á, Zorrilla I, Mané A, Rodríguez R, Corripio I, Sarró S, Ibáñez Á, Usall J, Rivero O, Gassó P, Leza JC, Cuesta MJ, Parellada M, González A, Berrocoso E, Mas S, Bernardo M, Amoretti S, Morén C, Urbiola E, González J, Roldán A, Catalán A, González I, Toll A, Legido T, Sanchez L, Dompablo M, Pomarol E, R L-R, Butjosa A, Rubio E, L, Ribeiro M, López I, León L, Nácher J, Contretas F, Lobo A, Gutiérrez M, Sáiz PA, 2EPs G. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57. DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5,6 (Q1/2D). Document type: Article.
Martinez E, Serra P, Bassa A, Palao DJ, Cardoner N. Discontinuation of maintenance electroconvulsive therapy: Lessons learned from the COVID-19 pandemic. Revista de Psiquiatria y Salud Mental. 2022; 15(2). DOI:10.1016/j.rpsm.2021.07.005. PMID:34329756. IF:9,2 (Q1/1D). Document type: Letter.
Mendez I, Sintes A, Pascual JC, Punti J, Lara A, Briones L, Nicolaou S, Schmidt C, Romero S, Fernandez M, Farres C, Soler J, Santamarina P, Vega D. Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302. DOI:10.1016/j.jad.2022.01.065. PMID:35038480. IF:6,6 (Q1/2D). Document type: Article.
Mendoza S, Garcia H, Lopez R, Sevilla J, Birules I, Barajas A, Lorente E, Gutierrez A, Grasa E, Pousa E, Pelaez T, Barrigon ML, Gonzalez F, Ruiz I, Cid J, Montserrat R, Martin L, Moreno B, Vila R, Diaz L, Verdaguer M, Ferrer M, Punsoda P, Barrau P, Moritz S, Ochoa S. Influence of Maternal and Paternal History of Mental Health in Clinical, Social Cognition and Metacognitive Variables in People with First-Episode Psychosis. Journal of Personalized Medicine. 2022; 12(10):1732. DOI:10.3390/jpm12101732. PMID:36294871. Document type: Article.
Miquel N, Vicent M, Martínez I, Porta D, Mar L, López M, Andrews JR, Soriano C, Menchón JM, Cardoner N, Alonso P, Serra M, López C. Terapia cognitiva basada en mindfulness: eficacia y predictores de respuesta con RM-funcional en pacientes con trastorno obsesivo-compulsivo. Protocolo de estudio para un ensayo clínico aleatorizado. Revista de Psiquiatria y Salud Mental. DOI:10.1016/j.rpsm.2022.11.002. IF:9,2 (Q1/1D). Document type: Article.
Montanes B, Bort J, Pascual JC, Soler J, Briones L. Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review. ACTA NEUROLOGICA SCANDINAVICA. 2022; 146(5). DOI:10.1111/ane.13709. PMID:36121184. IF:3,5 (Q2/4D). Document type: Review.
Montejo L, Sole B, Jimenez E, Borras R, Clougher D, Reinares M, Portella MJ, Martinez A, Vieta E, Bonnin CD, Torrent C. Aging in bipolar disorder: Cognitive performance and clinical factors based on an adulthood-lifespan perspective. JOURNAL OF AFFECTIVE DISORDERS. 2022; 312. DOI:10.1016/j.jad.2022.06.030. PMID:35752219. IF:6,6 (Q1/2D). Document type: Article.
Nunez C, Stephan C, Arca G, Agut T, Arnaez J, Cordeiro M, Benavente I, Boronat N, Lubian SP, Valverde E, Hortiguela M, Garcia A. Neonatal arterial stroke location is associated with outcome at 2 years: a voxel-based lesion-symptom mapping study. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2022; 107(1). DOI:10.1136/archdischild-2020-320400. PMID:33990386. IF:4,4 (Q1/1D). Document type: Article.
Perez M, Elvira U, Garcia G, Gadea M, Aguilar EJ, Escarti MJ, Ahullo MA, Grasa E, Corripio I, Sanjuan J, Nacher J. Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. NeuroImage-Clinical. 2022; 35:103070. DOI:10.1016/j.nicl.2022.103070. PMID:35667173. IF:4,2 (Q2/3D). Document type: Article.
Perez V, Villalba G, Elices M, Manero RM, Salgado P, Gines JM, Guardiola R, Cedron C, Polo M, Delgado I, Conesa G, Medrano S, Portella MJ. Cognitive and quality-of-life related factors of body mass index (BMI) improvement after deep brain stimulation in the subcallosal cingulate and nucleus accumbens in treatment-refractory chronic anorexia nervosa. EUROPEAN EATING DISORDERS REVIEW. 2022; 30(4). DOI:10.1002/erv.2895. PMID:35322504. IF:5,3 (Q1/2D). Document type: Article.
Pinzon J, van der Horst M, Zinkstok J, Austin J, Aalfs C, Batalla A, Sullivan P, Vorstman J, Luykx JJ. Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe. Translational Psychiatry. 2022; 12(1):442. DOI:10.1038/s41398-022-02203-6. PMID:36220808. IF:6,8 (Q1/2D). Document type: Article.
Porta D, Cano M, Steward T, Andero R, Cardoner N. The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. Neurobiology of Stress. 2022; 18:100448. DOI:10.1016/j.ynstr.2022.100448. PMID:35685680. IF:5 (Q2/3D). Document type: Article.
Pousa E, Brebion G, Lopez R, Ruiz AI, Grasa E, Barajas A, Pelaez T, A, Lorente E, Barrigon ML, Ruiz I, Gonzalez F, Cid J, Perez V, Ochoa S, Spanish Metacognition Study GRP, Insight Barcelona Work GRP. Clinical insight in first-episode psychosis: Clinical, neurocognitive and metacognitive predictors. SCHIZOPHRENIA RESEARCH. 2022; 248. DOI:10.1016/j.schres.2022.08.007. PMID:36063607. IF:4,5 (Q2/4D). Document type: Article.
Pujol N, Bergé D, Mané A, Bioque M, Mezquida G, Amoretti S, Baeza I, González A, Lobo A, Cuesta MJ, Ribeiro M, Sánchez G, Pérez V, Verdolini N, Vieta E, Parellada M, Roldán A, Bernardo M, PEPs G. The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study. PSYCHIATRY RESEARCH. 2022; 316:114760. DOI:10.1016/j.psychres.2022.114760. PMID:35977447. IF:11,3 (Q1/1D). Document type: Article.
Rodríguez E, Martínez K, Fraguas D, Janssen J, Pina L, Arias B, Vieta E, Mezquida G, Amoretti S, Bernardo M, Castro J, Cuesta MJ, Lobo A, González A, Collado IC, Mané A, Arango C, Parellada M, PEPs G. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity. Revista de Psiquiatria y Salud Mental. 2022; 15(2). DOI:10.1016/j.rpsm.2021.11.002. PMID:35840287. IF:9,2 (Q1/1D). Document type: Article.
Rodriguez N, Gasso P, Martinez A, Segura AG, Mezquida G, Moreno L, Gonzalez J, Zorrilla I, Martin M, Rodriguez R, Corripio I, Sarro S, Ibanez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, Mas S, Amoretti SS, Moren C, Stella C, Gurriaran X, Alonso A, Grasa E, Fernandez J, Gonzalez I, Casanovas F, Bulbuena A, Nunez A, Jimenez O, Pomarol E, Feria I, Usall J, Munoz D, Ilundain JL, Sanchez AM, Saiz J, Lopez I, Nacher J, De C, Gutierrez M, Saiz PA, 2EPS GRP. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. 2022; 8(1):45. DOI:10.1038/s41537-022-00215-1. PMID:35853879. Document type: Article.
Ruiz I, Moreno B, Garcia M, Barrigon ML, Gonzalez F, Lopez R, Barrios I, Barajas A, Pousa E, Lorente E, Grasa E, Cid J, Barrau P, Moritz S, Ochoa S, Spanish G. Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?. PSYCHIATRY RESEARCH. 2022; 318:114941. DOI:10.1016/j.psychres.2022.114941. PMID:36375331. IF:11,3 (Q1/1D). Document type: Article.
Sampedro F, Aracil I, Farres C, Soler J, Schmidt C, Elices M, Pomarol E, Salvador R, Vega D, Pascual JC. A Functional Connectivity Study to Investigate the Role of the Right Anterior Insula in Modulating Emotional Dysfunction in Borderline Personality Disorder. PSYCHOSOMATIC MEDICINE. 2022; 84(1). DOI:10.1097/PSY.0000000000001019. PMID:34611112. IF:3,3 (Q2/4D). Document type: Article.
Sánchez AM, Peralta V, Gil GJ, Mezquida G, Ribeiro M, Molina M, Amoretti S, Lobo A, González A, Merchán J, Corripio I, Vieta E, de la Serna E, Bergé D, Bernardo M, Cuesta MJ, Cabrera B, Pons M, Abregú R, Rapado M, Alonso A, Grasa E, González I, Alberich S, de la Cámara C, Saz P, Aguilar EJ, Escartí MJ, Martínez L, Toll A, Gavin P, Varo C, Baeza I, Puig O, Contreras F, Saiz C, Álvarez LG, Bascarán MTB, Fraile MG, Rabadán AZ, Sanchez L, Rodriguez R, Usall J, Butjosa A, Sarró S, Landín R, Ibáñez Á, Moreno L, Balanzá V, PEPs G. The network structure of cognitive deficits in first episode psychosis patients. SCHIZOPHRENIA RESEARCH. 2022; 244. DOI:10.1016/j.schres.2022.05.005. PMID:35594732. IF:4,5 (Q2/4D). Document type: Article.
Sanchez Y, de la Torre A, Portella MJ, Leal I, Salvat N, Massaneda C, de Arriba A, Urretavizcaya M, Pereto M, Toll A, Martinez A, Ferreiros R, Alvarez P, Soria V, Lopez P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. PSYCHONEUROENDOCRINOLOGY. 2022; 137:105631. DOI:10.1016/j.psyneuen.2021.105631. PMID:34929555. IF:3,7 (Q2/5D). Document type: Article.
Segura AG, Martinez A, Gasso P, Rodriguez N, Bioque M, Cuesta MJ, Gonzalez J, Garcia C, Lobo A, Gonzalez A, Garcia A, Roldan A, Vista E, Castro J, Mane A, Saiz J, Bernardo M, Mas S, PEPs GRP. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. SCHIZOPHRENIA RESEARCH. 2022; 244. DOI:10.1016/j.schres.2022.05.021. PMID:35659654. IF:4,5 (Q2/4D). Document type: Article.
Segura À-G, Prohens L, Mezquida G, Amoretti S, Bioque M, Ribeiro M, Gurriarán X, Rementería L, Berge D, Rodriguez R, Roldán A, Pomarol E, Ibáñez A, Usall J, García MP, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, Mas S, González JM, Arbelo N, González J, Pina L, Diestre A, Selma J, Zorrilla I, López P, Trabsa A, Monserrat C, Sanchez L, Nuñez A, Fatjó M, Sarró S, Butjosa A, Pardo M, López JM, Sánchez AM, Saiz J, Ochoa E, RIevero O, De C, Echevarría RS, González L, 2EPS G. Epigenetic clocks in relapse after a first episode of schizophrenia. SCHIZOPHRENIA. 2022; 8(1):61. DOI:10.1038/s41537-022-00268-2. Document type: Article.
Serra M, Amoretti S, Verdolini N, Forte MF, Sanchez AM, Vieta E, Clougher D, Lobo A, Gonzalez A, Panadero R, Roldan A, Carvalho AF, de la Serna E, Toll A, Ramos JA, Torrent C, Cuesta MJ, Bernardo M. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females. Frontiers in Psychiatry. 2022; 13:982583. DOI:10.3389/fpsyt.2022.982583. PMID:36339856. IF:4,7 (Q2/4D). Document type: Article.
Soler J, Casellas E, Fernandez I, Martin A, Almenta D, Pascual JC. «Skills for pills»: The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. ACTA PSYCHIATRICA SCANDINAVICA. 2022; 145(4). DOI:10.1111/acps.13403. PMID:35088405. IF:6,7 (Q1/2D). Document type: Article.
Soler J, Casellas E, Pascual JC, Schmidt C, Domínguez E, Cebolla A, Alvear D, Muro A, Elices M. Advancing the treatment of long-lasting borderline personality disorder: a feasibility and acceptability study of an expanded DBT-based skills intervention. Borderline Personality Disorder and Emotion Dysregulation. 2022; 9(1):34. DOI:10.1186/s40479-022-00204-x. PMID:36503564. IF:4,1 (Q2/5D). Document type: Article.
Trujols J, Duran S, Portella MJ. Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. MEDICAL JOURNAL OF AUSTRALIA. 2022; 217(2). DOI:10.5694/mja2.51614. PMID:35753958. IF:11,4 (Q1/1D). Document type: Letter.
van LS, Toenders YJ, Avila A, Dinga R, Rabinowitz JA, Campos AI, Jahanshad N, Renteria ME, Schmaal L. Classification of suicidal thoughts and behaviour in children: results from penalised logistic regression analyses in the Adolescent Brain Cognitive Development study. BRITISH JOURNAL OF PSYCHIATRY. 2022; 220(4). DOI:10.1192/bjp.2022.7. PMID:35135639. IF:10,5 (Q1/1D). Document type: Article.
Vicent M, González S, Raventós B, Vera J, Marín ED, Sabaté C, Pérez J, Puigdemont D, de Diego J, Alemany C, Serra M, Cardoner N, Portella MJ. Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). JOURNAL OF AFFECTIVE DISORDERS. 2022; 310. DOI:10.1016/j.jad.2022.05.016. PMID:35545155. IF:6,6 (Q1/2D). Document type: Article.
Whittle S, Rakesh D, Schmaal L, Veltman DJ, Thompson PM, Singh A, Gonul AS, Aleman A, Demir AU, Krug A, Mwangi B, Kramer B, Baune BT, Stein DJ, Grotegerd D, Pomarol E, Rodriguez E, Melloni E, Benedetti F, Stein F, Grabe HJ, Volzke H, Gotlib IH, Nenadic I, Soares JC, Repple J, Sim K, Brosch K, Wittfeld K, Berger K, Hermesdorf M, Portella MJ, Sacchet MD, Wu MJ, Opel N, Groenewold NA, Gruber O, Fuentes P, Salvador R, Goya R, Sarro S, Poletti S, Meinert SL, Kircher T, Dannlowski U, Pozzi E. The Role of Educational Attainment and Brain Morphology in Major Depressive Disorder: Findings From the ENIGMA Major Depressive Disorder Consortium. Journal Of Psychopathology And Clinical Science. 2022; 131(6). DOI:10.1037/abn0000738. PMID:35653754. Document type: Article.
Wierenga LM, Doucet GE, Dima D, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnæs D, Alpert KI, Andreassen OA, Anticevic A, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, den A, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Calhoun VD, Canales EJ, Cannon DM, et al. [Portella MJ]. Greater male than female variability in regional brain structure across the lifespan. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25204. PMID:33044802. IF:4,8 (Q1/2D). Document type: Article.

Publicaciones 2021

Amoretti S, Mezquida G, Rosa AR, Bioque M, Cuesta MJ, Pina L, Garcia C, Barcones F, Gonzalez A, Merchan J, Corripio I, Vieta E, Baeza I, Cortizo R, Bonnin CM, Torrent C, Bernardo M, PEPs GRP. The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47. DOI:10.1016/j.euroneuro.2021.02.007. PMID:33658165. IF: 5,415
Amoretti S, Rabelo FD, Rosa AR, Mezquida G, Sanchez AM, Fraguas D, Cabrera B, Lobo A, Gonzalez A, Pina L, Corripio I, Vieta E, Torrent C, de la Serna E, Berge D, Bioque M, Garriga M, Serra M, Cuesta MJ, Bernardo M. Cognitive clusters in first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 237. DOI:10.1016/j.schres.2021.08.021. PMID:34481203. IF: 4,662
Amoretti S, Verdolini N, Mezquida G, Rabelo FD, Cuesta MJ, Pina L, Gomez M, De C, Gonzalez A, Diaz CM, Corripio I, Vieta E, de la Serna E, Mane A, Sole B, Carvalho AF, Serra M, Bernardo M. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47. DOI:10.1016/j.euroneuro.2021.01.095. PMID:33531261. IF: 5,415
Arnaiz JA, Rodrigues-Silva C, Mezquida G, Amoretti S, Cuesta MJ, Fraguas D, Lobo A, González-Pinto A, Díaz-Caneja MC, Corripio I, Vieta E, Baeza I, Mané A, García-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S; PEPs group. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis. Psychopharmacology (Berl). 2021;238(3):665-676. DOI:10.1007/s00213-020-05715-5. PMID: 33230696. IF: 4,415
Arranz MJ, Gallego C, Martin A, Soler J, Elices M, Dominguez E, Salazar J, Vega D, Briones L, Pascual JC. A genome-wide methylation study reveals X chromosome and childhood trauma methylation alterations associated with borderline personality disorder. Translational Psychiatry. 2021; 11(1):5. DOI:10.1038/s41398-020-01139-z. PMID:33414392. IF: 7,989
Baeza I, de la Serna E, Amoretti S, Cuesta MJ, Diaz CM, Mezquida G, Lobo A, Gonzalez A, Corripio I, Vieta E, Puig O, Legido T, Bioque M, Garcia C, Bernardo M, Castro J. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis. JOURNAL OF CLINICAL PSYCHIATRY. 2021; 82(6):21m13907. DOI:10.4088/JCP.21m13907. PMID:34529899. IF: 5,906
Ballesteros A, Torres A, Lopez J, Mezquida G, Lobo A, Gonzalez A, Pina L, Corripio I, Vieta E, de la Serna E, Mane A, Bioque M, Moreno L, Espliego A, Lorente R, Amoretti S, Bernardo M, Cuesta MJ. The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory. PSYCHOLOGICAL MEDICINE. 2021; 51(12):PII S003329172000080X. DOI:10.1017/S003329172000080X. PMID:32326991. IF: 10,592
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G, Corripio I, Mico JA. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. Revista de Psiquiatria y Salud Mental. 2021; 14(3). DOI:10.1016/j.rpsm.2020.07.004. PMID:33020032. IF: 6,795
Briones L, Ali I, Schmidt C, Nicolaou S, Pascual JC, Soler J, Vega D. Predicting Non-Suicidal Self-Injury in Young Adults with and without Borderline Personality Disorder: a Multilevel Approach Combining Ecological Momentary Assessment and Self-Report Measures. PSYCHIATRIC QUARTERLY. 2021; 92(3). DOI:10.1007/s11126-020-09875-7. PMID:33475912. IF: 3,504
Calabria M, Perez JP, Martinez S, Horta A, Carceller M, Kulisevsky J, Costa A. Language reconfiguration in bilinguals A study with Huntington’s disease patients. Linguistic Approaches to Bilingualism. 2021; 11(4). DOI:10.1075/lab.18022.cal. IF: 1,815
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, […] Santos A, Nuñez C; GENIPE Group; PROFEP Group. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021;30(9):1383-1390. DOI:10.1007/s00787-020-01618-0. PMID: 32865655. IF: 5,349
Casellas E, Raventos B, Pineiro M, Navarro H, Castillon M, Portella MJ, Martin A. A Real-World Study of the Association between a Brief Group Psychoeducation and the Course of Bipolar Disorder. International Journal of Environmental Research and Public Health. 2021; 18(9):5019. DOI:10.3390/ijerph18095019. PMID:34068535. IF: 4,614
Caso JR, MacDowell KS, Gonzalez A, Garcia S, de Diego J, Carceller M, Sarramea F, Caballero J, Gracia P, De la Camara C, Aguera L, Gomez ML, Alba C, Rodriguez JM, Leza JC. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Translational Psychiatry. 2021; 11(1):645. DOI:10.1038/s41398-021-01755-3. PMID:34934041. IF: 7,989
Cobo J, Coronas R, Pousa E, Oliva JC, Gimenez O, Esteba S, Novell R, Palao DJ, Caixas A. Multidimensional Evaluation of Awareness in Prader-Willi Syndrome. Journal of Clinical Medicine. 2021; 10(9):2007. DOI:10.3390/jcm10092007. PMID:34067179. IF: 964
Draganov M, Arranz MJ, Vives Y, Jubero M, de Diego J, Avila A, Puigdemont D, Portella MJ. Polymorphisms in the IL1-b gene are associated with increased Glu and Glx levels in treatment-resistant depression. PSYCHIATRY RESEARCH-NEUROIMAGING. 2021; 316:111348. DOI:10.1016/j.pscychresns.2021.111348. PMID:34371477. IF: 2,493
Feliu A, de Diego J, Luciano JV, Iraurgi I, Alemany C, Puigdemont D, Perez V, Portella MJ, Trujols J. Unhappy While Depressed: Examining the Dimensionality, Reliability and Validity of the Subjective Happiness Scale in a Spanish Sample of Patients with Depressive Disorders. International Journal of Environmental Research and Public Health. 2021; 18(20):10964. DOI:10.3390/ijerph182010964. PMID:34682709. IF: 4,614
Feliu A, Perez-Aranda A, Luciano JV, Demarzo M, Marino M, Soler J, Van Gordon W, Garcia-Campayo J, Montero-Marin J. Psychometric Properties of the 15-Item Five Facet Mindfulness Questionnaire in a Large Sample of Spanish Pilgrims. Mindfulness. 2021; 12(4): 852–862. DOI:10.1007/s12671-020-01549-6. IF: 3,801
Ferrer M, Fernandez D, Lopez R, Birules I, Barajas A, Lorente E, Diaz L, Verdaguer M, Garcia H, Sevilla J, Gutierrez A, Grasa E, Pousa E, Huerta E, Pelaez T, Barrigon ML, Gonzalez F, Ruiz I, Cid J, Moritz S, Ochoa S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition. NPJ Schizophrenia. 2021; 7(1):61. DOI:10.1038/s41537-021-00187-8. PMID:34887442. IF: 4,966
Gasso P, Rodriguez N, Martinez A, Mezquida G, Ribeiro M, Gonzalez J, Zorrilla I, Martinez L, Rodriguez R, Corripio I, Sarro S, Ibanez A, Usall J, Lobo A, Moren C, Cuesta MJ, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, Mas S. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood. Translational Psychiatry. 2021; 11(1):539. DOI:10.1038/s41398-021-01645-8. PMID:34667144. IF: 7,989
Gonzalez C, Birules I, Pousa E, Barrigon ML, Lopez R, Lorente E, Ayesa R, Setien E, Barajas A, Grasa EM, Ruiz I, Gonzalez F, Cid J, Ochoa S. Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 141. DOI:10.1016/j.jpsychires.2021.06.040. PMID:34186271. IF: 5,250
Gonzalez L, Garcia MP, Gutierrez M, Mezquida G, Cuesta MJ, Urbiola E, Amoretti S, Barcones F, Gonzalez A, Pina L, Corripio I, Vieta E, Baeza I, Toll A, Saiz PA, Bobes J, Bernardo M. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 236. DOI:10.1016/j.schres.2021.07.017. PMID:34365082. IF: 4,662
Gorwood P, Benichou J, Moore N, Álvarez Martínez E, Mertens J, Aguglia E, Figueira ML, Falkai P, Olivier V, Wattez M, Picarel-Blanchot F, de Bodinat C. The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2021;36(1):1-11. DOI:10.1002/hup.2759. PMID: 32976677. IF: 2,130
Gutiérrez F, Aluja A, Ruiz J, García LF, Gárriz M, Gutiérrez-Zotes A, Gallardo-Pujol D, Navarro-Haro MV, Alabèrnia-Segura M, Mestre-Pintó JI, Torrens M, Peri JM, Sureda B, Soler J, Pascual JC, Vall G, Calvo N, Ferrer M, Oltmanns JR, Widiger TA. Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical Sample. Assessment. 2021;28(3):759-772. DOI:10.1177/1073191120936357. PMID: 32583685. IF: 4,282
Molina M, Fraguas D, del Rey A, Mezquida G, Sanchez AM, Amoretti S, Lobo A, Gonzalez A, Andreu A, Corripio I, Vieta E, Baeza I, Mane A, Cuesta M, de la Serna E, Paya B, Zorrilla I, Arango C, Bernardo M, Rapado M, Parellada M, PEPs GRP. The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis. Journal of Clinical Medicine. 2021; 10(11):2474. DOI:10.3390/jcm10112474. PMID:34199653. IF: 4,964
Navarra-Ventura G, Vicent-Gil M, Serra-Blasco M, Massons C, Crosas JM, Cobo J, Jubert A, Jodar M, Fernández-Gonzalo S, Goldberg X, Palao D, Lahera G, Vieta E, Cardoner N. Group and sex differences in social cognition in bipolar disorder, schizophrenia/schizoaffective disorder and healthy people. Comprehensive Psychiatry. 2021; 109:152258. DOI:10.1016/j.comppsych.2021.152258. PMID: 34252633. IF: 7,211
Navarrete J, Herrero R, Soler J, Dominguez E, Banos R, Cebolla A. Assessing self-criticism and self-reassurance: Examining psychometric properties and clinical usefulness of the Short-Form of the Forms of Self-Criticizing/Attacking & Self-Reassuring Scale (FSCRS-SF) in Spanish sample. PLoS One. 2021; 16(5):e0252089. DOI:10.1371/journal.pone.0252089. PMID:34029355. IF: 3,752
Pascual JC, Martin A, Soler J. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain. CNS DRUGS. 2021; 35(9). DOI:10.1007/s40263-021-00852-7. PMID:34370282. IF: 6,497
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abe C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargallo N, Bau CHD, Baumeister S, et al. [Portella MJ]. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021; 78(1). DOI:10.1001/jamapsychiatry.2020.2694. PMID:32857118. IF: 25,911
Roberto N, Portella MJ, Marquie M, Alegret M, Hernandez I, Mauleon A, Rosende M, Abdelnour C, de Antonio EE, Tartari JP, Vargas L, Lopez R, Bojaryn U, Espinosa A, Ortega G, Perez A, Sanabria A, Orellana A, de Rojas I, Moreno S, Montrreal L, Alarcon E, Ruiz A, Tarraga L, Boada M, Valero S. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 2021; 13:718949. DOI:10.3389/fnagi.2021.718949. PMID:34955804. IF: 5,702
Roberto N, Portella MJ, Marquie M, Alegret M, Hernandez I, Mauleon A, Rosende M, Abdelnour C, de Antonio EE, Gil S, Tartari JP, Vargas L, Espinosa A, Ortega G, Perez A, Sanabria A, Orellana A, de Rojas I, Moreno S, Montrreal L, Alarcon E, Ruiz A, Tarraga L, Boada M, Valero S. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Scientific Reports. 2021; 11(1):6448. DOI:10.1038/s41598-021-83126-y. PMID:33742011. IF: 4,996
Salagre E, Grande I, Jimenez E, Mezquida G, Cuesta MJ, Llorente C, Amoretti S, Lobo A, Gonzalez A, Carballo JJ, Corripio I, Verdolini N, Castro J, Legido T, Carvalho AF, Vieta E, Bernardo M, PEPs GRP. Trajectories of suicidal ideation after first-episode psychosis: a growth mixture modeling approach. ACTA PSYCHIATRICA SCANDINAVICA. 2021; 143(5). DOI:10.1111/acps.13279. PMID:33501646. IF: 7,734
Salagre E, Grande I, Sole B, Mezquida G, Cuesta MJ, Diaz CM, Amoretti S, Lobo A, Gonzalez A, Moreno C, Pina L, Corripio I, Baeza I, Berge D, Verdolini N, Carvalho AF, Vieta E, Bernardo M. Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis. Journal of Clinical Medicine. 2021; 10(1):73. DOI:10.3390/jcm10010073. PMID:33379225. IF: 4,964
Sampedro F, Farres C, Soler J, Elices M, Schmidt C, Corripio I, Dominguez E, Pomarol E, Salvador R, Pascual JC. Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response. Brain Imaging and Behavior. 2021; 15(5). DOI:10.1007/s11682-021-00451-6. PMID:33634348. IF: 3,224
Sampedro F, Roldan A, Alonso A, Grasa E, Portella MJ, Aguilar EJ, Nunez F, Gomez B, Corripio I. Grey matter microstructural alterations in schizophrenia patients with treatment-resistant auditory verbal hallucinations. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 138. DOI:10.1016/j.jpsychires.2021.03.037. PMID:33852993. IF: 5,250
Sanchez Y, Portella MJ, Leal I, Salvat N, Etxandi M, de Arriba A, Urretavizcaya M, Pousa E, Toll A, Alvarez P, Soria V, Lopez P. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder. JOURNAL OF AFFECTIVE DISORDERS. 2021; 279. DOI:10.1016/j.jad.2020.10.032. PMID:33099048. IF: 6,533
Sastre A, Ochoa S, Lorente E, Barajas A, Grasa E, Lopez R, Luengo A, Ruiz I, Cid J, Gonzalez F, Sanchez S, Baca E, Barrigon ML, Spanish Metacognition Study GRP. Jumping to conclusions and suicidal behavior in depression and psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 137. DOI:10.1016/j.jpsychires.2021.03.024. PMID:33812324. IF: 5,250
Schmidt C, Soler J, Farres C, Elices M, Dominguez E, Vega D, Pascual JC. Mindfulness in Borderline Personality Disorder: Decentering Mediates the Effectiveness. PSICOTHEMA. 2021; 33(3). DOI:10.7334/psicothema2020.437. PMID:34297670. IF: 4,104
Seppala A, Pylvanainen J, Lehtiniemi H, Hirvonen N, Corripio I, Koponen H, Seppala J, Ahmed A, Isohanni M, Miettunen J, Jaaskelainen E. Predictors of response to pharmacological treatments in treatment-resistant schizophrenia – A systematic review and meta-analysis. SCHIZOPHRENIA RESEARCH. 2021; 236. DOI:10.1016/j.schres.2021.08.005. PMID:34496316. IF: 4,662
Soler J, Montero J, Domínguez E, González S, Pascual JC, Cebolla A, Demarzo M, Analayo B, García J. Decentering, Acceptance, and Non-Attachment: Challenging the Question “Is It Me?”. Frontiers in Psychiatry. 2021; 12:659835. DOI:10.3389/fpsyt.2021.659835. IF: 5,435
Verdolini N, Amoretti S, Mezquida G, Cuesta MJ, Pina L, Garcia C, Lobo A, Gonzalez A, Merchan J, Corripio I, Salagre E, Baeza I, Berge D, Garriga M, Bioque M, Vallespir C, Serra M, Vieta E, Bernardo M. The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 49. DOI:10.1016/j.euroneuro.2021.03.015. PMID:33857739. IF: 5,415
Vicent M, Portella MJ, Serra M, Navarra G, Crivilles S, Aguilar E, Palao D, Cardoner N. Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach. PSYCHOLOGICAL MEDICINE. 2021; 51(16):PII S0033291720001567. DOI:10.1017/S0033291720001567. PMID:32476636. IF: 10,592

Presentación

Principales líneas de investigación

Trastornos Afectivos y Suicidio: esta línea de investigación estudia el trastorno depresivo mayor y el suicidio, en estrecha colaboración con otras líneas de investigación dentro del grupo.
Jefes de línea: Narcís Cardoner y Javier de Diego.
Trastornos Psicóticos: estudios relacionados con la esquizofrenia resistente y el tratamiento metacognitivo para pacientes con esquizofrenia.
Jefes de línea: Eva Grasa y Alexandra Roldán.
Trastorno Límite de la Personalidad: investigación en nuevos enfoques psicoterapéuticos de tercera generación como Mindfulness, Terapia Dialéctica Conductual, Terapia de Aceptación y Compromiso y psicología positiva.
Jefe de línea: Joaquim Soler.
Trastornos de la Conducta Alimentaria: investigación orientada a estrategias de tratamiento basadas en la evidencia, principalmente intervenciones conductuales, con proyectos en marcha.
Jefes de línea: Mar Carceller Sindreu y Cristina Carmona.
Hospitalización Parcial en Domicilio (UPHAD) e Intervención Comunitaria: esta línea está centrada en estudios que evalúan las experiencias de atención de pacientes y cuidadores, así como la mejora de los tratamientos domiciliarios, con el objetivo de mejorar la calidad de vida de las personas.
Jefe de línea: Ana Martín Blanco.
Conductas Adictivas: estudios enfocados en el ámbito de los trastornos adictivos, incluyendo la perspectiva del usuario. Desarrollo y validación de escalas de satisfacción.
Jefe de línea: Joan Trujols.

Retos

Fomentar la investigación para reducir los costes sanitarios, sociales y personales de la enfermedad mental mediante la exploración de varias áreas como la epidemiología, etiopatogénesis, fisiopatología, prevención y tratamiento.
Fomentar la investigación en terapias de salud mental.
Fomentar la investigación para mejorar la calidad de vida de pacientes con trastornos mentales.

Equipo

Coordinación del grupo

PORTELLA MOLL, MARIA JESUS IR
mportella@santpau.cat

Miembros

Alemany Santamaria, Carlo FGS

Almenta Gallego, David FGS

Avila Parcet, Aina FGS

Borrell Pozo, Julia IR

Cano Catala, Marta IR

Carceller Sindreu, Maria del Mar FGS

Cardoner Alvarez, Narcis FGS

Carmona Farres, Cristina FGS

Carrasco Hernandez, Julia IR

Casellas Pujol, Elisabet FGS

Corripio Collado, Iluminada IR

De Diego Adeliño, Francisco Javier FGS

De la Peña Arteaga, Victor IR

Diaz Perez, Anna M. FGS

Farre Martinez, Adriana FGS

Faustino Bosch, Gloria IR

Gawron, Leonor Patricia FGS

Grasa Bello, Eva Maria CIBERSAM

Jaramillo Muñumer, Maria CIBERSAM

Jubero Urgell, Miriam IR

Madre Rull, Merce FGS

Martin Blanco, Ana FGS

Otero Castellanos, Daniela IR

Pascual Mateos, Juan Carlos FGS

Perez Blanco, Josefina FGS

Pousa Tomas, Esther FGS

Puigdemont Campos, Maria Dolors FGS

Roldan Bejarano, Alejandra FGS

Serrano Gimeno, Victor FGS

Soler Ribaudi, Joaquin FGS

Tiana Sastre, Thais FGS

Trujols Albet, Joan FGS

Vicent Gil, Muriel FGS

Producción científica

Publicaciones 2023

(JIF 2023)

Publicaciones 2022

(JIF 2022)

Aibar JÁ, Rodríguez R, de Diego FJ, Portella MJ, Álvarez MJ, Martín A, Puigdemont D, Molet J. Long-Term Results of Deep Brain Stimulation for Treatment-Resistant Depression: Outcome Analysis and Correlation With Lead Position and Electrical Parameters. Neurosurgery. 2022; 90(1). DOI:10.1227/NEU.0000000000001739. PMID:34982873. IF:4,8 (Q1/1D). Document type: Article.
Alvear D, Soler J, Cebolla A. Meditators’ Non-academic Definition of Mindfulness. Mindfulness. 2022; 13(6). DOI:10.1007/s12671-022-01899-3. PMID:35634214. IF:3,6 (Q2/4D). Document type: Article.
Amoretti S, Rosa AR, Mezquida G, Cabrera B, Ribeiro M, Molina M, Bioque M, Lobo A, Gonzalez A, Fraguas D, Corripio I, Vieta E, de la Serna E, Morro L, Garriga M, Torrent C, Cuesta MJ, Bernardo M, PEPs GRP. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. PSYCHOLOGICAL MEDICINE. 2022; 52(3):PII S0033291720002226. DOI:10.1017/S0033291720002226. PMID:32900395. IF:6,9 (Q1/2D). Document type: Article.
Amoretti S, Verdolini N, Varo C, Mezquida G, Sanchez AM, Vieta E, Garcia C, Lobo A, Gonzalez A, Abregu R, Corripio I, Serra M, de la Serna E, Mane A, Ramos JA, Ribases M, Cuesta MJ, Bernardo M. Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302. DOI:10.1016/j.jad.2022.01.077. PMID:35066012. IF:6,6 (Q1/2D). Document type: Article.
Aragones E, Lopez G, Cardoner N, Tome C, Porta D, Palao D, INDI Res Team I. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses. BMC HEALTH SERVICES RESEARCH. 2022; 22(1):446. DOI:10.1186/s12913-022-07872-z. PMID:35382822. IF:2,8 (Q3/6D). Document type: Article.
Baenas I, Etxandi M, Munguia L, Granero R, Mestre G, Sanchez I, Ortega E, Andreu A, Moize VL, Fernandez JM, Tinahones FJ, Dieguez C, Fruhbeck G, Le D, Tchanturia K, Karwautz A, Zeiler M, Imgart H, Zanko A, Favaro A, Claes L, Shekriladze I, Serrano E, Cecilia R, Rangil T, Loran ME, Soriano J, Carceller M, Navarrete R, Lozano M, Linares R, Gudiol C, Carratala J, et al. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study. 2022; 14(1):100. DOI:10.3390/nu14010100. PMID:35010974. IF:5,9 (Q1/2D). Document type: Article.
Bas JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, Jahanshad N, Thomopoulos SI, Thompson PM, Veltman DJ, Winkler AM, Lueken U, Pine DS, van der Wee NJA, Stein DJ, Agosta F, Åhs F, An I, Alberton BAV, Andreescu C, Asami T, Assaf M, Avery SN, Nicholas L, B, Barber JP, Battaglia M, Bayram A, Beesdo K, Benedetti F, Berta R, Björkstrand J, Blackford JU, et al. [Cardoner N, Porta-Casteràs D]. Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25100. PMID:32618421. IF:4,8 (Q1/2D). Document type: Review.
Bioque M, Matias AC, Llorca V, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Moreno C, Roldan A, Martinez A, Baeza I, Berge D, Garcia C, Herrero SM, Bernardo M, 2EPs GRP. Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study. SCHIZOPHRENIA BULLETIN. 2022; 48(6). DOI:10.1093/schbul/sbac089. PMID:35876785. IF:6,6 (Q1/3D). Document type: Article.
Bioque M, Mezquida G, Amoretti S, Garcia C, Lopez JM, Diaz CM, Zorrilla I, Mane A, Rodriguez R, Corripio I, Pomarol E, Ibanez A, Usall J, Contreras F, Mas S, Vazquez J, Cuesta MJ, Parellada M, Gonzalez A, Hidalgo M, Bernardo M, 2EPs GRP. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2022; 243. DOI:10.1016/j.schres.2022.02.026. PMID:35231832. IF:4,5 (Q2/4D). Document type: Article.
Cano M, Lee E, Worthley A, Ellard K, Barbour T, Soriano C, Camprodon JA. Electroconvulsive therapy effects on anhedonia and reward circuitry anatomy: A dimensional structural neuroimaging approach. JOURNAL OF AFFECTIVE DISORDERS. 2022; 313. DOI:10.1016/j.jad.2022.06.062. PMID:35764228. IF:6,6 (Q1/2D). Document type: Article.
Cobo J, Coronas R, Pousa E, Oliva J-C, Giménez O, Caixàs A. An adapted scale to evaluate insight in Prader-Willi Syndrome. MEDICINA CLINICA. 2022; 159(3). DOI:10.1016/j.medcli.2021.07.015. PMID:34696903. IF:3,9 (Q2/4D). Document type: Article.
Corripio I, Roldan A, McKenna P, Sarro S, Alonso A, Salgado L, Alvarez E, Molet J, Pomarol E, Portella M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112:110436. DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5,6 (Q1/2D). Document type: Article.
Cuesta MJ, Ballesteros A, Sanchez AM, Amoretti S, Lopez JM, Merchan J, Gonzalez I, Salgado P, Rodriguez R, Roldan A, Sarro S, Ibanez A, Usall J, Escarti MJ, Moreno L, Mezquida G, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, 2Eps GRP. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden. SCHIZOPHRENIA RESEARCH. 2022; 248. DOI:10.1016/j.schres.2022.09.014. PMID:36155307. IF:4,5 (Q2/4D). Document type: Article.
De Diego J, Crespo JM, Mora F, Neyra A, Iborra P, Gutierrez L, Salonia SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opinion On Drug Safety. 2022; 21(5). DOI:10.1080/14740338.2022.2019705. PMID:34964415. IF:3,1 (Q3/6D). Document type: Review.
Diaz L, Lopez R, Garcia H, Ferrer M, Verdaguer M, Barajas A, Grasa E, Pousa E, Lorente E, Barrigon ML, Ruiz I, Gonzalez F, Cid J, Mas L, Corripio I, Birules I, Pelaez T, Luengo A, Beltran M, Torres P, Palma C, Moritz S, Garety P, Ochoa S, Spanish GRP. The relationship between jumping to conclusions and social cognition in first-episode psychosis. SCHIZOPHRENIA. 2022; 8(1):39. DOI:10.1038/s41537-022-00221-3. PMID:35853903. Document type: Article.
Dima D, Modabbernia A, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, et al. [Portella MJ]. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25320. PMID:33570244. IF:4,8 (Q1/2D). Document type: Article.
Dominguez E, Soler J, Elices M, Franquesa A, Alvarez E, Pascual JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2022; 37(1):e2807. DOI:10.1002/hup.2807. PMID:34411343. IF:1,7 (Q3/8D). Document type: Article.
Erausquin JT, Sánchez J, Yu A, Jhangimal M, Millender E, Peña Y, Ng W, Reina A, Nakad C, Quintana J, Herrera R, Vistica G, Pinzón J, Cabezas G, Katz J, Pascale JM, Rodríguez F, Gabster A. Sexual and reproductive health and access: Results of a rapid epidemiological assessment among migrant peoples in transit through Darién, Panamá. Frontiers In Reproductive Health. 2022; 4:953979. DOI:10.3389/frph.2022.953979. Document type: Article.
Ferrer M, Fernandez D, Lopez R, Birules I, Barajas A, Lorente E, Luengo A, Diaz L, Verdaguer M, Garcia H, Gutierrez A, Grasa E, Pousa E, Huerta E, Pelaez T, Barrigon ML, Gomez J, Gonzalez F, Ruiz I, Cid J, Moritz S, Sevilla J, Ochoa S, Spanish GRP. Males and females with first episode psychosis present distinct profiles of social cognition and metacognition. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022; 272(7). DOI:10.1007/s00406-022-01438-0. PMID:35802165. IF:4,7 (Q1/3D). Document type: Article.
Ferrer M, Fernandez D, Lopez R, Diaz L, Verdaguer M, Garcia H, Huerta E, Gomez J, Pelaez T, Birules I, Barajas A, Pousa E, Barrigon M, Gutierrez A, Grasa E, Ruiz I, Lorente E, Cid J, Ochoa S, Spanish Metacognition Study GRP. Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis. 2022; 10(11):2155. DOI:10.3390/healthcare10112155. PMID:36360496. IF:2,8 (Q3/6D). Document type: Article.
Fouche JP, Groenewold NA, Sevenoaks T, Heany S, Lochner C, Alonso P, Batistuzzo MC, Cardoner N, Ching CRK, de Wit SJ, Gutman B, Hoexter MQ, Jahanshad N, Kim M, Kwon JS, Mataix D, Menchon JM, Miguel EC, Nakamae T, Phillips ML, Pujol J, Sakai Y, Yun JY, Soriano C, Thompson PM, Yamada K, Veltman DJ, van den Heuvel OA, Stein DJ. Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium. Brain and Behavior. 2022; 12(10):e2755. DOI:10.1002/brb3.2755. PMID:36106505. IF:3,1 (Q2/3D). Document type: Article.
Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, et al. [Portella MJ]. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25364. PMID:33595143. IF:4,8 (Q1/2D). Document type: Article.
Garcia C, Cabrera B, Bioque M, Mezquida G, Lobo A, Gonzalez A, Diaz CM, Corripio I, Vieta E, Baeza I, Garcia MP, Gutierrez M, Rodriguez R, Garriga M, Fernandez E, Bernardo M, PEPs G. The effect of early life events on glucose levels in first-episode psychosis. Frontiers in Endocrinology. 2022; 13:983792. DOI:10.3389/fendo.2022.983792. PMID:36545332. IF:5,2 (Q1/3D). Document type: Article.
Kong X-Z, Mathias SR, Guadalupe T, Abé C, Akudjedu TN, Aleman A, Alhusaini S, Allen NB, Ames D, Andreassen OA, Vasquez AA, Armstrong NJ, Asherson P, Bergo F, Bastin ME, Batalla A, Bauer J, Baune BT, Baur R, Biederman J, Blaine SK, Boedhoe P, Bøen E, Bose A, Bralten J, Brandeis D, Brem S, Brodaty H, Yüksel D, Brooks SJ, Buitelaar J, Bürger C, Bülow R, Calhoun V, Calvo A, et al. [Portella MJ]. Reproducibility in the absence of selective reporting: An illustration from large-scale brain asymmetry research. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25154. PMID:32841457. IF:4,8 (Q1/2D). Document type: Article.
Lorente E, Grasa E, Ochoa S, Corripio I, Peláez T, López R, Gutiérrez Á, Morano M, Villagrán JM, Bartels AA, Jenner JA, Sanjuán J. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI). Revista de Psiquiatria y Salud Mental. 2022; 15(4). DOI:10.1016/j.rpsm.2020.03.002. PMID:32493672. IF:9,2 (Q1/1D). Document type: Article.
Martín A, Calvo L, Baccarin J, González A, Keymer A, Vieira S, Ribas N, Garcia C. Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice. Revista de Psiquiatria y Salud Mental. 2022; 15(3). DOI:10.1016/j.rpsm.2021.11.001. PMID:36272741. IF:9,2 (Q1/1D). Document type: Letter.
Martínez A, Mezquida G, Bioque M, López JM, Andreu Á, Zorrilla I, Mané A, Rodríguez R, Corripio I, Sarró S, Ibáñez Á, Usall J, Rivero O, Gassó P, Leza JC, Cuesta MJ, Parellada M, González A, Berrocoso E, Mas S, Bernardo M, Amoretti S, Morén C, Urbiola E, González J, Roldán A, Catalán A, González I, Toll A, Legido T, Sanchez L, Dompablo M, Pomarol E, R L-R, Butjosa A, Rubio E, L, Ribeiro M, López I, León L, Nácher J, Contretas F, Lobo A, Gutiérrez M, Sáiz PA, 2EPs G. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57. DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5,6 (Q1/2D). Document type: Article.
Martinez E, Serra P, Bassa A, Palao DJ, Cardoner N. Discontinuation of maintenance electroconvulsive therapy: Lessons learned from the COVID-19 pandemic. Revista de Psiquiatria y Salud Mental. 2022; 15(2). DOI:10.1016/j.rpsm.2021.07.005. PMID:34329756. IF:9,2 (Q1/1D). Document type: Letter.
Mendez I, Sintes A, Pascual JC, Punti J, Lara A, Briones L, Nicolaou S, Schmidt C, Romero S, Fernandez M, Farres C, Soler J, Santamarina P, Vega D. Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302. DOI:10.1016/j.jad.2022.01.065. PMID:35038480. IF:6,6 (Q1/2D). Document type: Article.
Mendoza S, Garcia H, Lopez R, Sevilla J, Birules I, Barajas A, Lorente E, Gutierrez A, Grasa E, Pousa E, Pelaez T, Barrigon ML, Gonzalez F, Ruiz I, Cid J, Montserrat R, Martin L, Moreno B, Vila R, Diaz L, Verdaguer M, Ferrer M, Punsoda P, Barrau P, Moritz S, Ochoa S. Influence of Maternal and Paternal History of Mental Health in Clinical, Social Cognition and Metacognitive Variables in People with First-Episode Psychosis. Journal of Personalized Medicine. 2022; 12(10):1732. DOI:10.3390/jpm12101732. PMID:36294871. Document type: Article.
Miquel N, Vicent M, Martínez I, Porta D, Mar L, López M, Andrews JR, Soriano C, Menchón JM, Cardoner N, Alonso P, Serra M, López C. Terapia cognitiva basada en mindfulness: eficacia y predictores de respuesta con RM-funcional en pacientes con trastorno obsesivo-compulsivo. Protocolo de estudio para un ensayo clínico aleatorizado. Revista de Psiquiatria y Salud Mental. DOI:10.1016/j.rpsm.2022.11.002. IF:9,2 (Q1/1D). Document type: Article.
Montanes B, Bort J, Pascual JC, Soler J, Briones L. Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review. ACTA NEUROLOGICA SCANDINAVICA. 2022; 146(5). DOI:10.1111/ane.13709. PMID:36121184. IF:3,5 (Q2/4D). Document type: Review.
Montejo L, Sole B, Jimenez E, Borras R, Clougher D, Reinares M, Portella MJ, Martinez A, Vieta E, Bonnin CD, Torrent C. Aging in bipolar disorder: Cognitive performance and clinical factors based on an adulthood-lifespan perspective. JOURNAL OF AFFECTIVE DISORDERS. 2022; 312. DOI:10.1016/j.jad.2022.06.030. PMID:35752219. IF:6,6 (Q1/2D). Document type: Article.
Nunez C, Stephan C, Arca G, Agut T, Arnaez J, Cordeiro M, Benavente I, Boronat N, Lubian SP, Valverde E, Hortiguela M, Garcia A. Neonatal arterial stroke location is associated with outcome at 2 years: a voxel-based lesion-symptom mapping study. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2022; 107(1). DOI:10.1136/archdischild-2020-320400. PMID:33990386. IF:4,4 (Q1/1D). Document type: Article.
Perez M, Elvira U, Garcia G, Gadea M, Aguilar EJ, Escarti MJ, Ahullo MA, Grasa E, Corripio I, Sanjuan J, Nacher J. Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. NeuroImage-Clinical. 2022; 35:103070. DOI:10.1016/j.nicl.2022.103070. PMID:35667173. IF:4,2 (Q2/3D). Document type: Article.
Perez V, Villalba G, Elices M, Manero RM, Salgado P, Gines JM, Guardiola R, Cedron C, Polo M, Delgado I, Conesa G, Medrano S, Portella MJ. Cognitive and quality-of-life related factors of body mass index (BMI) improvement after deep brain stimulation in the subcallosal cingulate and nucleus accumbens in treatment-refractory chronic anorexia nervosa. EUROPEAN EATING DISORDERS REVIEW. 2022; 30(4). DOI:10.1002/erv.2895. PMID:35322504. IF:5,3 (Q1/2D). Document type: Article.
Pinzon J, van der Horst M, Zinkstok J, Austin J, Aalfs C, Batalla A, Sullivan P, Vorstman J, Luykx JJ. Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe. Translational Psychiatry. 2022; 12(1):442. DOI:10.1038/s41398-022-02203-6. PMID:36220808. IF:6,8 (Q1/2D). Document type: Article.
Porta D, Cano M, Steward T, Andero R, Cardoner N. The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. Neurobiology of Stress. 2022; 18:100448. DOI:10.1016/j.ynstr.2022.100448. PMID:35685680. IF:5 (Q2/3D). Document type: Article.
Pousa E, Brebion G, Lopez R, Ruiz AI, Grasa E, Barajas A, Pelaez T, A, Lorente E, Barrigon ML, Ruiz I, Gonzalez F, Cid J, Perez V, Ochoa S, Spanish Metacognition Study GRP, Insight Barcelona Work GRP. Clinical insight in first-episode psychosis: Clinical, neurocognitive and metacognitive predictors. SCHIZOPHRENIA RESEARCH. 2022; 248. DOI:10.1016/j.schres.2022.08.007. PMID:36063607. IF:4,5 (Q2/4D). Document type: Article.
Pujol N, Bergé D, Mané A, Bioque M, Mezquida G, Amoretti S, Baeza I, González A, Lobo A, Cuesta MJ, Ribeiro M, Sánchez G, Pérez V, Verdolini N, Vieta E, Parellada M, Roldán A, Bernardo M, PEPs G. The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study. PSYCHIATRY RESEARCH. 2022; 316:114760. DOI:10.1016/j.psychres.2022.114760. PMID:35977447. IF:11,3 (Q1/1D). Document type: Article.
Rodríguez E, Martínez K, Fraguas D, Janssen J, Pina L, Arias B, Vieta E, Mezquida G, Amoretti S, Bernardo M, Castro J, Cuesta MJ, Lobo A, González A, Collado IC, Mané A, Arango C, Parellada M, PEPs G. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity. Revista de Psiquiatria y Salud Mental. 2022; 15(2). DOI:10.1016/j.rpsm.2021.11.002. PMID:35840287. IF:9,2 (Q1/1D). Document type: Article.
Rodriguez N, Gasso P, Martinez A, Segura AG, Mezquida G, Moreno L, Gonzalez J, Zorrilla I, Martin M, Rodriguez R, Corripio I, Sarro S, Ibanez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, Mas S, Amoretti SS, Moren C, Stella C, Gurriaran X, Alonso A, Grasa E, Fernandez J, Gonzalez I, Casanovas F, Bulbuena A, Nunez A, Jimenez O, Pomarol E, Feria I, Usall J, Munoz D, Ilundain JL, Sanchez AM, Saiz J, Lopez I, Nacher J, De C, Gutierrez M, Saiz PA, 2EPS GRP. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. 2022; 8(1):45. DOI:10.1038/s41537-022-00215-1. PMID:35853879. Document type: Article.
Ruiz I, Moreno B, Garcia M, Barrigon ML, Gonzalez F, Lopez R, Barrios I, Barajas A, Pousa E, Lorente E, Grasa E, Cid J, Barrau P, Moritz S, Ochoa S, Spanish G. Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?. PSYCHIATRY RESEARCH. 2022; 318:114941. DOI:10.1016/j.psychres.2022.114941. PMID:36375331. IF:11,3 (Q1/1D). Document type: Article.
Sampedro F, Aracil I, Farres C, Soler J, Schmidt C, Elices M, Pomarol E, Salvador R, Vega D, Pascual JC. A Functional Connectivity Study to Investigate the Role of the Right Anterior Insula in Modulating Emotional Dysfunction in Borderline Personality Disorder. PSYCHOSOMATIC MEDICINE. 2022; 84(1). DOI:10.1097/PSY.0000000000001019. PMID:34611112. IF:3,3 (Q2/4D). Document type: Article.
Sánchez AM, Peralta V, Gil GJ, Mezquida G, Ribeiro M, Molina M, Amoretti S, Lobo A, González A, Merchán J, Corripio I, Vieta E, de la Serna E, Bergé D, Bernardo M, Cuesta MJ, Cabrera B, Pons M, Abregú R, Rapado M, Alonso A, Grasa E, González I, Alberich S, de la Cámara C, Saz P, Aguilar EJ, Escartí MJ, Martínez L, Toll A, Gavin P, Varo C, Baeza I, Puig O, Contreras F, Saiz C, Álvarez LG, Bascarán MTB, Fraile MG, Rabadán AZ, Sanchez L, Rodriguez R, Usall J, Butjosa A, Sarró S, Landín R, Ibáñez Á, Moreno L, Balanzá V, PEPs G. The network structure of cognitive deficits in first episode psychosis patients. SCHIZOPHRENIA RESEARCH. 2022; 244. DOI:10.1016/j.schres.2022.05.005. PMID:35594732. IF:4,5 (Q2/4D). Document type: Article.
Sanchez Y, de la Torre A, Portella MJ, Leal I, Salvat N, Massaneda C, de Arriba A, Urretavizcaya M, Pereto M, Toll A, Martinez A, Ferreiros R, Alvarez P, Soria V, Lopez P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. PSYCHONEUROENDOCRINOLOGY. 2022; 137:105631. DOI:10.1016/j.psyneuen.2021.105631. PMID:34929555. IF:3,7 (Q2/5D). Document type: Article.
Segura AG, Martinez A, Gasso P, Rodriguez N, Bioque M, Cuesta MJ, Gonzalez J, Garcia C, Lobo A, Gonzalez A, Garcia A, Roldan A, Vista E, Castro J, Mane A, Saiz J, Bernardo M, Mas S, PEPs GRP. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. SCHIZOPHRENIA RESEARCH. 2022; 244. DOI:10.1016/j.schres.2022.05.021. PMID:35659654. IF:4,5 (Q2/4D). Document type: Article.
Segura À-G, Prohens L, Mezquida G, Amoretti S, Bioque M, Ribeiro M, Gurriarán X, Rementería L, Berge D, Rodriguez R, Roldán A, Pomarol E, Ibáñez A, Usall J, García MP, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, Mas S, González JM, Arbelo N, González J, Pina L, Diestre A, Selma J, Zorrilla I, López P, Trabsa A, Monserrat C, Sanchez L, Nuñez A, Fatjó M, Sarró S, Butjosa A, Pardo M, López JM, Sánchez AM, Saiz J, Ochoa E, RIevero O, De C, Echevarría RS, González L, 2EPS G. Epigenetic clocks in relapse after a first episode of schizophrenia. SCHIZOPHRENIA. 2022; 8(1):61. DOI:10.1038/s41537-022-00268-2. Document type: Article.
Serra M, Amoretti S, Verdolini N, Forte MF, Sanchez AM, Vieta E, Clougher D, Lobo A, Gonzalez A, Panadero R, Roldan A, Carvalho AF, de la Serna E, Toll A, Ramos JA, Torrent C, Cuesta MJ, Bernardo M. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females. Frontiers in Psychiatry. 2022; 13:982583. DOI:10.3389/fpsyt.2022.982583. PMID:36339856. IF:4,7 (Q2/4D). Document type: Article.
Soler J, Casellas E, Fernandez I, Martin A, Almenta D, Pascual JC. «Skills for pills»: The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. ACTA PSYCHIATRICA SCANDINAVICA. 2022; 145(4). DOI:10.1111/acps.13403. PMID:35088405. IF:6,7 (Q1/2D). Document type: Article.
Soler J, Casellas E, Pascual JC, Schmidt C, Domínguez E, Cebolla A, Alvear D, Muro A, Elices M. Advancing the treatment of long-lasting borderline personality disorder: a feasibility and acceptability study of an expanded DBT-based skills intervention. Borderline Personality Disorder and Emotion Dysregulation. 2022; 9(1):34. DOI:10.1186/s40479-022-00204-x. PMID:36503564. IF:4,1 (Q2/5D). Document type: Article.
Trujols J, Duran S, Portella MJ. Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. MEDICAL JOURNAL OF AUSTRALIA. 2022; 217(2). DOI:10.5694/mja2.51614. PMID:35753958. IF:11,4 (Q1/1D). Document type: Letter.
van LS, Toenders YJ, Avila A, Dinga R, Rabinowitz JA, Campos AI, Jahanshad N, Renteria ME, Schmaal L. Classification of suicidal thoughts and behaviour in children: results from penalised logistic regression analyses in the Adolescent Brain Cognitive Development study. BRITISH JOURNAL OF PSYCHIATRY. 2022; 220(4). DOI:10.1192/bjp.2022.7. PMID:35135639. IF:10,5 (Q1/1D). Document type: Article.
Vicent M, González S, Raventós B, Vera J, Marín ED, Sabaté C, Pérez J, Puigdemont D, de Diego J, Alemany C, Serra M, Cardoner N, Portella MJ. Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). JOURNAL OF AFFECTIVE DISORDERS. 2022; 310. DOI:10.1016/j.jad.2022.05.016. PMID:35545155. IF:6,6 (Q1/2D). Document type: Article.
Whittle S, Rakesh D, Schmaal L, Veltman DJ, Thompson PM, Singh A, Gonul AS, Aleman A, Demir AU, Krug A, Mwangi B, Kramer B, Baune BT, Stein DJ, Grotegerd D, Pomarol E, Rodriguez E, Melloni E, Benedetti F, Stein F, Grabe HJ, Volzke H, Gotlib IH, Nenadic I, Soares JC, Repple J, Sim K, Brosch K, Wittfeld K, Berger K, Hermesdorf M, Portella MJ, Sacchet MD, Wu MJ, Opel N, Groenewold NA, Gruber O, Fuentes P, Salvador R, Goya R, Sarro S, Poletti S, Meinert SL, Kircher T, Dannlowski U, Pozzi E. The Role of Educational Attainment and Brain Morphology in Major Depressive Disorder: Findings From the ENIGMA Major Depressive Disorder Consortium. Journal Of Psychopathology And Clinical Science. 2022; 131(6). DOI:10.1037/abn0000738. PMID:35653754. Document type: Article.
Wierenga LM, Doucet GE, Dima D, Agartz I, Aghajani M, Akudjedu TN, Albajes A, Alnæs D, Alpert KI, Andreassen OA, Anticevic A, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, den A, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Calhoun VD, Canales EJ, Cannon DM, et al. [Portella MJ]. Greater male than female variability in regional brain structure across the lifespan. HUMAN BRAIN MAPPING. 2022; 43(1). DOI:10.1002/hbm.25204. PMID:33044802. IF:4,8 (Q1/2D). Document type: Article.

Publicaciones 2021

Amoretti S, Mezquida G, Rosa AR, Bioque M, Cuesta MJ, Pina L, Garcia C, Barcones F, Gonzalez A, Merchan J, Corripio I, Vieta E, Baeza I, Cortizo R, Bonnin CM, Torrent C, Bernardo M, PEPs GRP. The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47. DOI:10.1016/j.euroneuro.2021.02.007. PMID:33658165. IF: 5,415
Amoretti S, Rabelo FD, Rosa AR, Mezquida G, Sanchez AM, Fraguas D, Cabrera B, Lobo A, Gonzalez A, Pina L, Corripio I, Vieta E, Torrent C, de la Serna E, Berge D, Bioque M, Garriga M, Serra M, Cuesta MJ, Bernardo M. Cognitive clusters in first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 237. DOI:10.1016/j.schres.2021.08.021. PMID:34481203. IF: 4,662
Amoretti S, Verdolini N, Mezquida G, Rabelo FD, Cuesta MJ, Pina L, Gomez M, De C, Gonzalez A, Diaz CM, Corripio I, Vieta E, de la Serna E, Mane A, Sole B, Carvalho AF, Serra M, Bernardo M. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47. DOI:10.1016/j.euroneuro.2021.01.095. PMID:33531261. IF: 5,415
Arnaiz JA, Rodrigues-Silva C, Mezquida G, Amoretti S, Cuesta MJ, Fraguas D, Lobo A, González-Pinto A, Díaz-Caneja MC, Corripio I, Vieta E, Baeza I, Mané A, García-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S; PEPs group. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis. Psychopharmacology (Berl). 2021;238(3):665-676. DOI:10.1007/s00213-020-05715-5. PMID: 33230696. IF: 4,415
Arranz MJ, Gallego C, Martin A, Soler J, Elices M, Dominguez E, Salazar J, Vega D, Briones L, Pascual JC. A genome-wide methylation study reveals X chromosome and childhood trauma methylation alterations associated with borderline personality disorder. Translational Psychiatry. 2021; 11(1):5. DOI:10.1038/s41398-020-01139-z. PMID:33414392. IF: 7,989
Baeza I, de la Serna E, Amoretti S, Cuesta MJ, Diaz CM, Mezquida G, Lobo A, Gonzalez A, Corripio I, Vieta E, Puig O, Legido T, Bioque M, Garcia C, Bernardo M, Castro J. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis. JOURNAL OF CLINICAL PSYCHIATRY. 2021; 82(6):21m13907. DOI:10.4088/JCP.21m13907. PMID:34529899. IF: 5,906
Ballesteros A, Torres A, Lopez J, Mezquida G, Lobo A, Gonzalez A, Pina L, Corripio I, Vieta E, de la Serna E, Mane A, Bioque M, Moreno L, Espliego A, Lorente R, Amoretti S, Bernardo M, Cuesta MJ. The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory. PSYCHOLOGICAL MEDICINE. 2021; 51(12):PII S003329172000080X. DOI:10.1017/S003329172000080X. PMID:32326991. IF: 10,592
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G, Corripio I, Mico JA. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. Revista de Psiquiatria y Salud Mental. 2021; 14(3). DOI:10.1016/j.rpsm.2020.07.004. PMID:33020032. IF: 6,795
Briones L, Ali I, Schmidt C, Nicolaou S, Pascual JC, Soler J, Vega D. Predicting Non-Suicidal Self-Injury in Young Adults with and without Borderline Personality Disorder: a Multilevel Approach Combining Ecological Momentary Assessment and Self-Report Measures. PSYCHIATRIC QUARTERLY. 2021; 92(3). DOI:10.1007/s11126-020-09875-7. PMID:33475912. IF: 3,504
Calabria M, Perez JP, Martinez S, Horta A, Carceller M, Kulisevsky J, Costa A. Language reconfiguration in bilinguals A study with Huntington’s disease patients. Linguistic Approaches to Bilingualism. 2021; 11(4). DOI:10.1075/lab.18022.cal. IF: 1,815
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, […] Santos A, Nuñez C; GENIPE Group; PROFEP Group. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021;30(9):1383-1390. DOI:10.1007/s00787-020-01618-0. PMID: 32865655. IF: 5,349
Casellas E, Raventos B, Pineiro M, Navarro H, Castillon M, Portella MJ, Martin A. A Real-World Study of the Association between a Brief Group Psychoeducation and the Course of Bipolar Disorder. International Journal of Environmental Research and Public Health. 2021; 18(9):5019. DOI:10.3390/ijerph18095019. PMID:34068535. IF: 4,614
Caso JR, MacDowell KS, Gonzalez A, Garcia S, de Diego J, Carceller M, Sarramea F, Caballero J, Gracia P, De la Camara C, Aguera L, Gomez ML, Alba C, Rodriguez JM, Leza JC. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Translational Psychiatry. 2021; 11(1):645. DOI:10.1038/s41398-021-01755-3. PMID:34934041. IF: 7,989
Cobo J, Coronas R, Pousa E, Oliva JC, Gimenez O, Esteba S, Novell R, Palao DJ, Caixas A. Multidimensional Evaluation of Awareness in Prader-Willi Syndrome. Journal of Clinical Medicine. 2021; 10(9):2007. DOI:10.3390/jcm10092007. PMID:34067179. IF: 964
Draganov M, Arranz MJ, Vives Y, Jubero M, de Diego J, Avila A, Puigdemont D, Portella MJ. Polymorphisms in the IL1-b gene are associated with increased Glu and Glx levels in treatment-resistant depression. PSYCHIATRY RESEARCH-NEUROIMAGING. 2021; 316:111348. DOI:10.1016/j.pscychresns.2021.111348. PMID:34371477. IF: 2,493
Feliu A, de Diego J, Luciano JV, Iraurgi I, Alemany C, Puigdemont D, Perez V, Portella MJ, Trujols J. Unhappy While Depressed: Examining the Dimensionality, Reliability and Validity of the Subjective Happiness Scale in a Spanish Sample of Patients with Depressive Disorders. International Journal of Environmental Research and Public Health. 2021; 18(20):10964. DOI:10.3390/ijerph182010964. PMID:34682709. IF: 4,614
Feliu A, Perez-Aranda A, Luciano JV, Demarzo M, Marino M, Soler J, Van Gordon W, Garcia-Campayo J, Montero-Marin J. Psychometric Properties of the 15-Item Five Facet Mindfulness Questionnaire in a Large Sample of Spanish Pilgrims. Mindfulness. 2021; 12(4): 852–862. DOI:10.1007/s12671-020-01549-6. IF: 3,801
Ferrer M, Fernandez D, Lopez R, Birules I, Barajas A, Lorente E, Diaz L, Verdaguer M, Garcia H, Sevilla J, Gutierrez A, Grasa E, Pousa E, Huerta E, Pelaez T, Barrigon ML, Gonzalez F, Ruiz I, Cid J, Moritz S, Ochoa S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition. NPJ Schizophrenia. 2021; 7(1):61. DOI:10.1038/s41537-021-00187-8. PMID:34887442. IF: 4,966
Gasso P, Rodriguez N, Martinez A, Mezquida G, Ribeiro M, Gonzalez J, Zorrilla I, Martinez L, Rodriguez R, Corripio I, Sarro S, Ibanez A, Usall J, Lobo A, Moren C, Cuesta MJ, Parellada M, Gonzalez A, Berrocoso E, Bernardo M, Mas S. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood. Translational Psychiatry. 2021; 11(1):539. DOI:10.1038/s41398-021-01645-8. PMID:34667144. IF: 7,989
Gonzalez C, Birules I, Pousa E, Barrigon ML, Lopez R, Lorente E, Ayesa R, Setien E, Barajas A, Grasa EM, Ruiz I, Gonzalez F, Cid J, Ochoa S. Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 141. DOI:10.1016/j.jpsychires.2021.06.040. PMID:34186271. IF: 5,250
Gonzalez L, Garcia MP, Gutierrez M, Mezquida G, Cuesta MJ, Urbiola E, Amoretti S, Barcones F, Gonzalez A, Pina L, Corripio I, Vieta E, Baeza I, Toll A, Saiz PA, Bobes J, Bernardo M. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 236. DOI:10.1016/j.schres.2021.07.017. PMID:34365082. IF: 4,662
Gorwood P, Benichou J, Moore N, Álvarez Martínez E, Mertens J, Aguglia E, Figueira ML, Falkai P, Olivier V, Wattez M, Picarel-Blanchot F, de Bodinat C. The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2021;36(1):1-11. DOI:10.1002/hup.2759. PMID: 32976677. IF: 2,130
Gutiérrez F, Aluja A, Ruiz J, García LF, Gárriz M, Gutiérrez-Zotes A, Gallardo-Pujol D, Navarro-Haro MV, Alabèrnia-Segura M, Mestre-Pintó JI, Torrens M, Peri JM, Sureda B, Soler J, Pascual JC, Vall G, Calvo N, Ferrer M, Oltmanns JR, Widiger TA. Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical Sample. Assessment. 2021;28(3):759-772. DOI:10.1177/1073191120936357. PMID: 32583685. IF: 4,282
Molina M, Fraguas D, del Rey A, Mezquida G, Sanchez AM, Amoretti S, Lobo A, Gonzalez A, Andreu A, Corripio I, Vieta E, Baeza I, Mane A, Cuesta M, de la Serna E, Paya B, Zorrilla I, Arango C, Bernardo M, Rapado M, Parellada M, PEPs GRP. The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis. Journal of Clinical Medicine. 2021; 10(11):2474. DOI:10.3390/jcm10112474. PMID:34199653. IF: 4,964
Navarra-Ventura G, Vicent-Gil M, Serra-Blasco M, Massons C, Crosas JM, Cobo J, Jubert A, Jodar M, Fernández-Gonzalo S, Goldberg X, Palao D, Lahera G, Vieta E, Cardoner N. Group and sex differences in social cognition in bipolar disorder, schizophrenia/schizoaffective disorder and healthy people. Comprehensive Psychiatry. 2021; 109:152258. DOI:10.1016/j.comppsych.2021.152258. PMID: 34252633. IF: 7,211
Navarrete J, Herrero R, Soler J, Dominguez E, Banos R, Cebolla A. Assessing self-criticism and self-reassurance: Examining psychometric properties and clinical usefulness of the Short-Form of the Forms of Self-Criticizing/Attacking & Self-Reassuring Scale (FSCRS-SF) in Spanish sample. PLoS One. 2021; 16(5):e0252089. DOI:10.1371/journal.pone.0252089. PMID:34029355. IF: 3,752
Pascual JC, Martin A, Soler J. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain. CNS DRUGS. 2021; 35(9). DOI:10.1007/s40263-021-00852-7. PMID:34370282. IF: 6,497
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abe C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargallo N, Bau CHD, Baumeister S, et al. [Portella MJ]. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021; 78(1). DOI:10.1001/jamapsychiatry.2020.2694. PMID:32857118. IF: 25,911
Roberto N, Portella MJ, Marquie M, Alegret M, Hernandez I, Mauleon A, Rosende M, Abdelnour C, de Antonio EE, Tartari JP, Vargas L, Lopez R, Bojaryn U, Espinosa A, Ortega G, Perez A, Sanabria A, Orellana A, de Rojas I, Moreno S, Montrreal L, Alarcon E, Ruiz A, Tarraga L, Boada M, Valero S. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 2021; 13:718949. DOI:10.3389/fnagi.2021.718949. PMID:34955804. IF: 5,702
Roberto N, Portella MJ, Marquie M, Alegret M, Hernandez I, Mauleon A, Rosende M, Abdelnour C, de Antonio EE, Gil S, Tartari JP, Vargas L, Espinosa A, Ortega G, Perez A, Sanabria A, Orellana A, de Rojas I, Moreno S, Montrreal L, Alarcon E, Ruiz A, Tarraga L, Boada M, Valero S. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Scientific Reports. 2021; 11(1):6448. DOI:10.1038/s41598-021-83126-y. PMID:33742011. IF: 4,996
Salagre E, Grande I, Jimenez E, Mezquida G, Cuesta MJ, Llorente C, Amoretti S, Lobo A, Gonzalez A, Carballo JJ, Corripio I, Verdolini N, Castro J, Legido T, Carvalho AF, Vieta E, Bernardo M, PEPs GRP. Trajectories of suicidal ideation after first-episode psychosis: a growth mixture modeling approach. ACTA PSYCHIATRICA SCANDINAVICA. 2021; 143(5). DOI:10.1111/acps.13279. PMID:33501646. IF: 7,734
Salagre E, Grande I, Sole B, Mezquida G, Cuesta MJ, Diaz CM, Amoretti S, Lobo A, Gonzalez A, Moreno C, Pina L, Corripio I, Baeza I, Berge D, Verdolini N, Carvalho AF, Vieta E, Bernardo M. Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis. Journal of Clinical Medicine. 2021; 10(1):73. DOI:10.3390/jcm10010073. PMID:33379225. IF: 4,964
Sampedro F, Farres C, Soler J, Elices M, Schmidt C, Corripio I, Dominguez E, Pomarol E, Salvador R, Pascual JC. Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response. Brain Imaging and Behavior. 2021; 15(5). DOI:10.1007/s11682-021-00451-6. PMID:33634348. IF: 3,224
Sampedro F, Roldan A, Alonso A, Grasa E, Portella MJ, Aguilar EJ, Nunez F, Gomez B, Corripio I. Grey matter microstructural alterations in schizophrenia patients with treatment-resistant auditory verbal hallucinations. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 138. DOI:10.1016/j.jpsychires.2021.03.037. PMID:33852993. IF: 5,250
Sanchez Y, Portella MJ, Leal I, Salvat N, Etxandi M, de Arriba A, Urretavizcaya M, Pousa E, Toll A, Alvarez P, Soria V, Lopez P. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder. JOURNAL OF AFFECTIVE DISORDERS. 2021; 279. DOI:10.1016/j.jad.2020.10.032. PMID:33099048. IF: 6,533
Sastre A, Ochoa S, Lorente E, Barajas A, Grasa E, Lopez R, Luengo A, Ruiz I, Cid J, Gonzalez F, Sanchez S, Baca E, Barrigon ML, Spanish Metacognition Study GRP. Jumping to conclusions and suicidal behavior in depression and psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 137. DOI:10.1016/j.jpsychires.2021.03.024. PMID:33812324. IF: 5,250
Schmidt C, Soler J, Farres C, Elices M, Dominguez E, Vega D, Pascual JC. Mindfulness in Borderline Personality Disorder: Decentering Mediates the Effectiveness. PSICOTHEMA. 2021; 33(3). DOI:10.7334/psicothema2020.437. PMID:34297670. IF: 4,104
Seppala A, Pylvanainen J, Lehtiniemi H, Hirvonen N, Corripio I, Koponen H, Seppala J, Ahmed A, Isohanni M, Miettunen J, Jaaskelainen E. Predictors of response to pharmacological treatments in treatment-resistant schizophrenia – A systematic review and meta-analysis. SCHIZOPHRENIA RESEARCH. 2021; 236. DOI:10.1016/j.schres.2021.08.005. PMID:34496316. IF: 4,662
Soler J, Montero J, Domínguez E, González S, Pascual JC, Cebolla A, Demarzo M, Analayo B, García J. Decentering, Acceptance, and Non-Attachment: Challenging the Question “Is It Me?”. Frontiers in Psychiatry. 2021; 12:659835. DOI:10.3389/fpsyt.2021.659835. IF: 5,435
Verdolini N, Amoretti S, Mezquida G, Cuesta MJ, Pina L, Garcia C, Lobo A, Gonzalez A, Merchan J, Corripio I, Salagre E, Baeza I, Berge D, Garriga M, Bioque M, Vallespir C, Serra M, Vieta E, Bernardo M. The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 49. DOI:10.1016/j.euroneuro.2021.03.015. PMID:33857739. IF: 5,415
Vicent M, Portella MJ, Serra M, Navarra G, Crivilles S, Aguilar E, Palao D, Cardoner N. Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach. PSYCHOLOGICAL MEDICINE. 2021; 51(16):PII S0033291720001567. DOI:10.1017/S0033291720001567. PMID:32476636. IF: 10,592

ENFERMEDADES NEUROLóGICAS, NEUROCIENCIA Y SALUD MENTAL

Salud Mental

Principales líneas de investigación

Retos

Coordinación del grupo

Miembros

Publicaciones 2023

Publicaciones 2022

Publicaciones 2021

Principales líneas de investigación

Retos

Coordinación del grupo

Miembros

Publicaciones 2023

Publicaciones 2022

Publicaciones 2021

Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau